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ABSTRACT 
 
 
Cancer is a major cause of death worldwide. Hence, there is a great need to 
develop novel therapeutic agents for the prevention and treatment of cancer in addition 
to conventional therapies. Dietary polyphenols are known to be effective in the 
prevention and treatment of several chronic diseases such as cancer, cardiovascular 
diseases, and diabetes. Particularly in carcinogenesis, polyphenols are known to suppress 
cancer growth, angiogenesis, and metastasis. Several studies have demonstrated that 
polyphenolics, ellagitannins, gallotannins, and chlorogenic acid from pomegranate, 
mango, and plum juice, respectively, are potent inhibitors of cancer cell proliferation and 
induce apoptosis and cell cycle arrest as well as decrease inflammation in vitro and vivo.  
The therapeutically relevant compounds in pomegranate are ellagic acid, 
ellagitannins, flavonoids, and 3-glucosides/3,5-diglucosides of the anthocyanins 
delphinidin, cyanidin, and pelargonidin that exerted antioxidant, anti-inflammatory, and 
anticarcinogenic activities in vitro and vivo. Mango pulp extract contains gallotannins, 
gallic acid, galloyl glycosides, and flavonoids such as quercetin and kaempferol 
glycosides, which showed antioxidant, anti-inflammatory, and anticarcinogenic activities 
in vitro and in vivo. Chlorogenic acid and neo-chlorogenic acid are contained in plum 
juice and are also known to function as chemoprevention and chemotherapeutic agents. 
The overall objective of this work was to investigate the underlying anti-
inflammatory and cytotoxic mechanisms involving miR-27a-ZBTB10-Sp and miR-155-
SHIP-1-PI3K axes, miR126-VCAM-1, miR126-PI3K/AKT-mTOR and 
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miR143/PI3K/AKT/mTOR axes in polyphenol-mediated anti-inflammatory and 
anticarcinogenic activities in vitro and vivo.  
Pomegranate and Mango polyphenols exhibited antioxidant, anti-inflammatory, 
anticarcinogenic, and antiproliferative activities in vitro and in vivo. Polyphenols 
inhibited cell proliferation of breast cancer cell line BT474 and suppressed tumor growth 
in athymic BALB/c nude mice with BT474 xenografts. Interactions of Pg with miR-27a-
ZBTB10-Sp and miR-155-SHIP-1-PI3K axes and mango miR126/PI3K/AKT axis were 
identified. In addition, pomegranate and plum polyphenols exerted cytotoxic and anti-
inflammatory effects in azoxymethane AOM-treated rats and colon cancer cells. 
Interactions of Pg with miR126/VCAM-1 and miR126/PI3K/AKT/mTOR axes and plum 
with miR143/PI3K/AKT/mTOR were identified as mechanisms that at least in part 
appear to be involved in the anti-inflammatory and antiproliferative activities of 
pomegranate and plum polyphenolics.  
The presented research was conducted in order to understand the efficacy of 
polyphenols present in pomegranate, mango and plum and their underlying molecular 
mechanisms in different cancer models. 
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CHAPTER I 
INTRODUCTION: SIGNIFICANCE OF POLYPHENOLIC COMPOUNDS IN 
CANCER THERAPY 
  
Background    
Cancer is a major health care problem in the United States and worldwide and 
is the second most common cause of death in the United States, exceeded only by 
cardiovascular disease. Currently, 1 in 4 deaths in the United States is related to cancer 
and  2012,  it was estimated that approximately 1,638,910 new cancer cases will  have 
been diagnosed; among these, about 577,190 deaths are estimated. [1-3]. From 1998 to 
2007, the overall cancer death rates decreased both in men and woman across all racial 
and ethnic groups [1-4]. Survival statistics are significantly influenced by demographic 
factors such as gender, age and country or region, as well as the type of cancer and stage 
at diagnosis [1-3].  
Between 2004 and 2008, the overall cancer occurrence rates decreased slightly 
in men (by 0.6% per year) but were stable in women and the cancer death rates were 
decreased by 1.8% per year in men and by 1.6% in women. Between 1999 and 2008, 
death rates from cancer decreased by more than 1% per year in men and women of every 
racial/ethnic group except for American Indians/Alaska whose death rates were 
unchanged [4]. These improved survival rate can be attributed to screening for certain 
cancers and detection at their early stages and in improved treatment regimens. 
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The most common cancers among men are cancers of the prostate, lung, and 
bronchus, as well as colon and rectal cancers and these accounted for about 52% of all 
newly diagnosed cancers in 2012. Among women, the three most commonly diagnosed 
types of cancers are breast, lung, and bronchus, followed by colon and rectal cancer, 
which combined accounted for 52% of estimated cancer cases in women in 2012 (Figure 
1) [4]. 
 
 
Figure 1 Estimated new cancer cases for each of ten major cancer types in the United States  (by sex), 
2012 [4] 
 
 
 
Death rates decreased for all 4 major cancer sites (lung, colorectum, breast, and 
prostate), with lung cancer accounting for almost 29% of the total decline in men and 
breast cancer accounting for 26% of the total decline in women (Figure 2). Further 
reduction in death due to cancer can be achieved through the improvement of cancer 
 3 
 
prevention and treatment, with emphasis on groups in the lowest socioeconomic bracket 
[4]. 
 
 
Figure 2 Estimated new cancer deaths, by gender, for ten major cancer types in United States, 2012 [4] 
 
 
 
Carcinogenesis is a multistep process involving uncontrolled cell proliferation, 
cellular transformation, and angiogenesis, in addition many tumors metastasize for distal 
sites where they continue to grow [4-9]. Carcinogenesis includes three steps tumor 
initiation, promotion and progression.  Carcinogens are agents involved in cancer 
initiation which can be influenced by inflammatory agents, genetic and epigenetic 
alterations or that can activate of oncogenes and initiate tumor suppressor genes. Cancer 
progression leads to gradual phenotypical changes, from a normal to a pre-neoplastic cell 
that may be further transformed into a neoplastic cell [4-9]. 
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Breast cancer  
Breast cancer is one of the leading causes of cancer death among women 
worldwide and the American Cancer Society has estimated of 226,870 new cases of 
breast cancer with 39,510 deaths from breast cancer in 2012 [1-4]. Breast cancer is the 
most common cancer after skin cancers in women throughout the world [1-4].   
The lifetime risk of developing breast cancer is about 1 in 8 (12%) among 
women in the United States. Interestingly breast cancer has accounted for 34% of the 
total decline in cancer in recent years and started the declining in 2000 after increasing 
for more than two decades .The use of hormone therapy is believed have contributed to 
this large decrease in breast cancer incidence. 
The chance of death from breast cancer among women in the United States is 
about 1 in 36 (about 3%) and eath rates from breast cancer have been decreasing since 
about 1989, with a larger decline in women younger than 50 years of age [4]. These 
decreases are thought to be the result of detection at earlier stages through improved 
screening and  treatment [4]. The incidence rate of breast cancer appears to be highest 
among whites, followed by African-Americans, whereas the mortality rates were highest 
among African Americans, followed by whites (Table 1) [4]. Of all breast cancer 
patients, the main cause of death is metastasis at distant sites [10]. Since the risk of 
metastasis cannot be predicted in patients with primary tumors, most patients undergo 
adjuvant therapy to eradicate breast tumor cells. Nevertheless some breast cancer 
patients die from metastasis, and from the toxic effect of extensive chemotherapy  [10]. 
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Table 1 Incidence and mortality rates by demography in the United States between 2004-2008 [4] 
Incidence 
  White  African American 
Asian 
American 
or Pacific 
Islander 
American 
Indian or 
Alaska 
Native 
Hispanic/Latino 
All Sites 
Male 546 626.2 332.4 427.8 423.4 
Female 420.8 394.2 284 362.1 333.5 
Breast (Female) 122.8 116.1 84.9 89.2 92.3 
Colorectum 
Male 54.6 66.9 42.4 51.5 48.6 
Female 40.8 49.7 32.7 41.5 34.2 
Kidney & 
renal Pelvis 
Male 20.8 22.6 9.9 27.4 19.4 
Female 10.9 11.7 4.9 16.8 11.2 
Liver & bile 
duct 
Male 8.6 14.1 21.7 15.8 17 
Female 2.9 4 8.2 7.6 6.4 
Lung & 
bronchus 
Male 63.7 102.7 49.8 71 46.8 
Female 57.2 51.4 28.1 51.7 27 
Prostate 142.8 230.8 79.7 101.2 126.7 
Stomach 
Male 8.5 16.4 16.8 13.9 13.8 
Female 4 8.2 9.4 6.8 8.4 
Uterine 
Cervix   7.7 10.6 7.4 9.8 12.2 
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Table 1 Continued 
Mortality 
  White  African American 
Asian 
American 
or Pacific 
Islander 
American 
Indian or 
Alaska 
Native 
Hispanic/Latino 
All Sites 
Male 222 295.3 184.7 190 149.1 
Female 152.8 177.7 94.1 138.4 101.5 
Breast (Female) 22.8 32 12.2 17.2 15.1 
Colorectum 
Male 20.1 30.5 18.8 19.8 15.5 
Female 24 20.4 9.9 14 10.3 
Kidney & 
renal Pelvis 
Male 6 6 2.6 8.9 5.2 
Female 2.7 2.6 1.2 4.1 2.8 
Liver & bile 
duct 
Male 7.2 11.5 14.7 11.9 11.6 
Female 8 8.9 6.9 6.7 5.2 
Lung & 
bronchus 
Male 86.9 85.4 86.7 80.5 31.9 
Female 41.2 38.8 38.5 33.9 14.3 
Prostate 22.4 54.9 10.5 20.7 18.5 
Stomach 
Male 4.6 10.7 9.2 8.5 7.7 
Female 2.8 5 5.4 3.9 4.5 
Uterine Cervix 2.2 4.8 2.1 3.4 3.1 
 
Colon cancer	  	  
According to the American Cancer Society, colorectal cancer is the third 
leading cause of death in the United States and then estimate 143460 new cases of 
colorectal cancer and 52,690 death in 2012 [1-3]. Colorectal cancer occurs equally  in 
both men and women.  
The incidence of colorectal cancer and associated mortality rate is increasing 
worldwide and the lifetime risk of developing colorectal cancer is about 1 in 20 [1-3]. 
Colorectal cancer incidence rates have been decreasing for the past two decades from 
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66.3 cases per 100,000 in 1985 to 46.4 per 100,000 in 2005. According to cancer 
statistics, this decrease is attributed to improved diagnosis, which helps early detection 
and removal of colorectal polyps before tumor formation.  
Death rates for colorectal cancer have decreased in both men and women over 
the last two decades, with a rapid decrease of 4.3% per year from 2002 to 2005 in both 
men and women, compared to 2.0% per year from 1990 to 2002 in men and 1.8% per 
year from 1984 to 2002 in women (1-3). The incidence and mortality rate of colorectal 
cancer appeared to be highest among African-Americans (Table 2) [4]. 
 
 
 
Figure 3 Hallmarks of cancer [11] 
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Hallmarks of cancer 
Tumor formation is accompanied by gradual phenotypic changes, from a 
normal to a preneoplastic cell that transforms to a neoplastic cell. Six hallmarks in 
cancer progression have been defined (Figure 3) self-sufficiency in growth signals, 
insensitivity to growth-inhibitory (antigrowth) signals, evasion of programmed cell death 
(apoptosis), limitless replicative potential, sustained angiogenesis, and tissue invasion 
and metastasis. 
1. Self-sufficiency in growth signals: In order to maintain normal cell 
homeostasis, non-transformed cells depend on growth factors to proliferate. These 
growth signals are transmitted through transmembrane receptors that are targets for 
various growth factors and extracellular matrix components (Figure 3). In contrast, 
cancer cells exhibit decreased dependency on exogenous growth factors. And became 
autonomous through auto-activation of several growth factors such as platelet derived 
growth factor (PDGF) vascular endothelial growth factor (VEGF), transforming growth 
factor, (TGF)  and epidermal growth factor (EGF).  Production of these growth factors 
result in autocrine stimulation through a positive feedback signaling loop [11]. 
2. Insensitivity to anti-growth signals: Antigrowth signals can inhibit cell 
proliferation either by moving cells out of the active proliferation cycle into a 
temporarily quiescent (G0) state or by permanently inhibiting cell proliferation whereby 
cells remain in a postmitotic state. Cancer cells escape these anti-proliferative signals. 
For example, Retinoblastoma (Rb), a tumor suppressor gene, plays a key role in the 
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transition from the quiescent (G0/G1) phase to the replicating (S) phase of the cell cycle 
and in cancer cells Rb can become inactivated[11].  
3. Evading apoptosis: A crucial mechanism of cell death is apoptosis which is a 
form of programmed cell death. In cancer, there is an imbalance between cell 
proliferation and cell death that can result in tumor growth of cells that escape apoptosis. 
In cancer cells the balance between antiapoptotic and pro-apoptotic signals is shifted and 
cancer cells can proliferate under adverse environmental conditions such as hypoxia, and 
chemotherapy which are toxic to normal cells  [11]. 
4. Limitless replicative potential: After a number of replications and cell 
divisions, normal cells stop growing and this stage is called senescence. However cancer 
cells acquire immortalization and fail to undergo cell death by increasing the activation 
of telomerase (hTERT) enzyme which is required for cell proliferation and  excess of 
telomere length [11]. This property is important for cancer cell progression and 
metastasis[11].  
5. Sustained angiogenesis: Neovascularization or formation of new blood 
vessels is enhanced during cancer progression. New blood vessels play important role 
for cancer cell survival and are essential for supplying oxygen and nutrients to the cancer 
cells. For example, increased expression of VEGF is observed in several cancer cells 
[11].  
6. Tissue invasion and metastasis: Cancer cells have the capability of invasion 
and metastasis and can migrate to distant organs and develop metastatic tumors and 
cancer cells. Metastasis of cancer cells is the major cause of death in cancer patients. 
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Cell-to-cell adhesion molecules such as cadherins and integrins influence the invasive 
and metastatic properties of cancer cells [11].  
Animal models used for breast cancer research  
The prevention and treatment of breast cancer, with various cytotoxic and 
endocrine therapies, have been somewhat successful however it is also important to 
develop novel therapies. [12-14]. In addition to progress in screening and assessment, 
the development of mouse xenograft models had played an important role in 
understanding breast tumor formation and progression. [12-14] and the heterogeneity of 
this diseases and these models are essential for drug development and determines their 
effectiveness in different types and subtypes of tumors [12-14]. The xenograft model 
provides reproducible characteristics and a unique opportunity to understand tumor 
growth regulation and metastasis in an in vivo environment [13, 14].   
It has been previously shown that some established human breast cancer cell 
are tumorigenic in immuno-compromised nude mice [12-14]. Studies have shown that 
human breast cancer cell xenografts can serve as an effective model of breast cancer 
growth and provide insight on mechanism of tumor growth and effectiveness of 
anticancer agents .[12, 13]. Breast cancer xenografts are implanted into the subcutaneous 
tissue of the flanks (Figure 7) or mammary fat pad (orthotopic site) [13, 14]. 
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Figure 4 Breast cancer xenografts are implanted into the subcutaneous tissue of the flanks 
 
 
 
Transgenic breast cancer model  
p53 knockout (p53–/–) animal model 
The first identified tumor suppressor gene was p53, which prevents neoplastic 
development by inhibiting abnormal cell proliferation [15]. p53 activation is mediated 
through several dependent pathways, such as kinases or independent pathways and also 
in response to cellular stresses [15]. p53 activity, decreased through mutations in tumor 
suppressor genes exhibits oncogenic activity through increased cell survival and 
genomic instability [15, 16]. p53 knockout model predicts significant possibility of 
developing human tumors with p53 mutation. Close association between p53 mutation 
with both spontaneous and inherited human tumors creates a better chance to develop a 
representative transgenic animal model for p53-related cancers [16] 
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PTEN knockout (PTEN–/–) animal model 
The PTEN (phosphatase and ten sin homolog deleted from chromosome 10), 
another important tumor-suppressor gene, also known as MMAC1 (mutated in multiple 
advanced cancers) is involved in cell cycle processes [17]. Mutations or somatic 
deletions of PTEN, may result in increased cell proliferation and leads to tumor growth. 
PTEN appears to be mutated in human cancers, such as prostrate breast cancer. PTEN 
controls AKT expression which reveals PTEN function as tumor suppressor gene 
through control of cell survival [17]. Studies have shown that mutation of one allele of 
PTEN can result in impaired apoptosis in a mouse model. Similarly loss of one allele 
plays an important role for early selection and detection of cells during transformation 
[17]. Thus PTEN knockout (PTEN–/–) animal model is used to study mammary 
tumorigenesis [17].  
ErB2 overexpression transgenic mice model 
The ErbB2 receptor tyrosine kinase gene (also known as HER-2; Human 
Epidermal Growth Factor Receptor 2; family or NEU, the rat homologue of ERBB2,) is 
overexpressed in many human invasive breast cancer [18].  Breast cancer cells with 
overexpression of ErbB2 showed resistance to some chemotherapeutic agents [18, 19]. 
Breast cancer patients receive a combination of cyclophosphamide, methotrexate, and 5-
fluorouracil (CMF) as chemotherapeutic agents [18]. However ErbB2-overexpressed 
breast cancer patients showed less response to CMF- chemotherapy agents than their 
counterpart with normal ErbB2 expression [18, 19]. To understand the molecular basis 
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of ERBB2-influenced mammary tumorigenesis, ErB2 overexpressed transgenic mice 
model have been developed [19]. 
The carcinogen-induced mammary carcinoma model 
Several carcinogen-induced mammary carcinoma model has been reported 
such as  methylcholanthrene (MCA) is a highly carcinogenic polycyclic aromatic 
hydrocarbon and 7,12-dimethylbenz(a)anthracene- (DMBA ) used as  potent carcinogens 
for mammary tumorigenesis, DMBA treated animal model closely mimics human 
mammary tumorigenesis as DMBA metabolites can cause DNA damage, which is a key 
event in carcinogenesis initiation [20]. 
Animal models used in colon cancer studies 
Chemical carcinogen models  
Experimental study of colon cancer in animal models has a long history of 80 
years [21, 22]. Several studies have shown the induction of colon tumorigenesis when 
mice or rats have been administered chemical carcinogens. For example, Lorenz et al., 
have shown that mice fed with the polycyclic aromatic hydrocarbon methylcholanthrene 
develop gastric and intestinal tumorigenesis. Lisco et al., have demonstrated that rats fed 
with radioactive yttrium develop colon tumorigenesis [22] and the most commonly used 
colon cancer carcinogens are 1,2-dimethlyhydrazine (DMH) or a zoxymethane (AOM) 
[22]. 
An early population study shows that the consumtion of cycad flour, a source 
of hydrazine, a colon carcinogen, caused colon carcinogenesis in the animals [22]. Other 
studies show that rats, fed with hydrazine rich cycad flour, developed adenocarcinomas 
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[22]. Cycad flour contains cycasins a form of methylazoxymethanol (MAM). Earlier 
studies have shown that DMH, a metabolic precursor of MAM, induce colon tumors in 
rats. It has been demonstrated that, as a carcinogen, AOM is more stable and more 
potent than DMH and  several thousand studies have been performed using AOM [22].  
There are a a number of advantages in using the carcinogen-induced colon 
cancer rodent model, the results are highly reproducible, and the animals with different 
genetic background can be used [22]. AOM-induced colon cancer pathogenesis re-
capitulates early stages of the human adenoma-carcinoma. So far, the majority of 
carcinogen-induced colon cancer models have been carried out in rats and in mouse 
models and studies with chemopreventive agents and dietary factors have also been 
performed in carcinogen-induced colon cancer models [21, 22]. 
Xenograft colon cancer model  
Another major model used for investigating colon cancer pathogenesis is the 
mouse xenograft model.  Human colon cancer cells are grafted into immuno- 
compromised nude mice predominantly into subcutaneous tissue [23]. Although 
subcutaneous sites are non-invasive and do not metastasize, these sites are optimal for 
the observation of tumor growth and progression [23]. Transplanting tumors into their 
orthotopic site such as in the cecum of nude mice may induce liver metastases. Human 
colon cancer cell suspensions have also been injected into the cecal wall. Colon cancer 
tissue implantation at the orthotopic site were found to be more metastatic than tumors 
obtained after tumor cell injections [23]. 
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Transgenic APC min/+ colon cancer model  
Adenomatous polyposis coli (APC) is a tumor suppressor gene encoded by the 
APC gene in human [24]. APC regulates the uncontrolled cell growth which causes 
cancerous tumors. APC gene protein controls cellular processes and function as a 
"gatekeeper" to inhibit colon tumor development [24-26]. Mutation in the adenomatous 
polyposis coli (APC) gene may result in sporadic colorectal tumors and also familial 
adenomatous polyposis (FAP), a hereditary form of colon cancer [24-26]. Hundreds to 
thousands of colorectal polyps developed in FAP human patients,  may further develop 
to colon carcinomas if not removed in a timely manner [27]. There is much interest in 
transgenic APC min/+ mouse for studying intestinal tumorigenesis underlying mechanisms 
and potential cancer prevention and treatment methods [25]. APC min/+ mouse survive 
about 120 days due to intestinal tumors which has a mutated APC gene, similar to FAP 
colon cancer. This animal model mimics the colon carcinomas and rapid development of 
polys in patients due to mutation of one APC gene [25]. 
Types characteristics and classification of breast cancer 
There are different types of breast cancer with distinct characteristics and 
occurrence frequency.  
Ductal carcinoma  
Mammary ductal carcinoma is the most common type of breast cancer of 
ductal carcinomas are predominant a) Ductal carcinoma in situ (DCIS) which is non-
invasive, with cancer cells inside the milk ducts (lactiferous ducts) that do not spread 
through the wall of the ducts into the surrounding breast tissue. b) Another form is 
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invasive ductal carcinoma (IDC), in which infiltrating, malignant neoplastic cells spread 
in the breast tissue  [28].  
Ductal carcinoma in situ  
Ductal carcinoma in situ (DCIS) is the most common form of non-invasive 
breast cancer. The meaning of “in situ” is   in its original place." DCIS is appeared to be 
"non-invasive" and does not spread beyond the milk duct into surrounding breast tissue. 
Most women diagnosed at an early stage of breast cancer ductal carcinoma in situ can be 
successfully treated. This has been shown About 1 in 5 new DCIS breast cancer cases. A 
mammogram is often the best way for early detection of DCIS. Later on DCIS 
can increase the risk of developing an invasive breast cancer [28]. 
Invasive (or infiltrating) ductal carcinoma  
The second most common type of breast cancer is an invasive (or infiltrating) 
form of ductal carcinoma (IDC). IDC develops inside a milk duct of the breast, spreads 
through the wall of the duct, and further develops and grows within the fatty tissue of the 
breast. It also has the potential to spread (metastasize) to other parts of the body through 
the lymphatic system and bloodstream. About 8 of 10 invasive breast cancers are IDC. 
Lobular carcinoma in situ 
Invasive (or infiltrating) lobular carcinoma 
Invasive lobular carcinoma (ILC) [28] initiates in the milk-producing glands 
(lobules) like IDC, and can also metastasize to other tissue of the body. About 1 in 10 
invasive breast cancers are ILC and diagnosis by mammograms has a lower success rate 
than for IDC. 
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Less common types of breast cancer 
Inflammatory breast cancer 
Inflammatory breast cancer accounts for about 1 to 3% of all breast cancers and 
this type of cancer usually develops without the formation of palpatable tumors. Instead, 
IBC makes the skin on the breast thick, look red and feel warm. Mammogramdo not 
detect this tumor and IBC readily metastasize  
Triple-negative breast cancer 
Triple-negative breast cancers (invasive ductal carcinomas) cells do not express 
estrogen or progesterone receptors, or human epidermal growth factor receptor 2 
(HER2) proteins on their surface. This type of breast cancer occurs more often in 
younger women and in African-American women and is known to spread more rapidly 
than most other types of breast cancer. Because the tumor cells lack of hormone 
receptors, hormone therapy or drug therapy that targets HER2 are not effective and 
alternative treatments are necessary.  
Paget disease of the breast 
Paget disease is a rare form of breast cancer which account for only 1% of all 
breast cancer cases. It starts in the breast ducts and spreads to the skin of the nipple and 
then to the areola.  
Phyllodes tumor  
This is very rare form of breast cancer that develops in the stroma (connective 
tissue) of the breast.  Unlike carcinomas, it does not form in the ducts or lobules. These 
tumors are usually benign but in rare cases may be malignant.  
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Angiosarcoma 
Angiosarcoma initiates in cells that line blood vessels or lymph vessels. 
Although it rarely occurs in the breast when it does, it generally develops as a 
complication of previous irradiation treatments.  
Risk factors of breast cancer 
Genetics and specific mutated genes 
A woman with first degree relatives (such as mother, sister, or daughter) who 
has been diagnosed with breast has a higher chance of developing breast cancer than a 
woman without a family history of cancer. Cancer in the family h doubles the chance of 
being diagnosed with cancer because cancer is usually caused by an inherited gene 
mutation. Among the several breast cancer associated that are inherited; the most 
common are BRCA1 and BRCA2 [28]. Inherited mutations in these genes cause 
hereditary breast and ovarian cancer syndrome (HBOC). It is more likely that someone 
has inherited a particular form of breast cancer if the person is diagnosed at an early age, 
especially if they have relatives with the disease. 
Environmental and dietary factors  
Dietary and environmental factors have a strong influence on development of 
several types of cancer. For instance meat consumption of red meats that are associated 
with a higher incidence of colon cancer and the consumption of fat associated with 
breast cancer Dietary and environmental variables have strong influences on several 
types of cancer. For instance, meat consumption is often linked with colon cancer and fat 
consumption is often linked with breast cancer [29, 30]. 
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Increased risk of breast cancer has been associated with a diet high in saturated 
fat during early adulthood  [31, 32].  The fatty acid composition in dairy or animal 
sources is significantly different from vegetable sources. Animal fat consists of saturated 
and monounsaturated fatty acids, but vegetable fat is primarily polyunsaturated and/or 
monounsaturated. there is a significant correlation between the intake of animal fat and 
the incidence of mammary tumorigenesis [31, 32].  
Types characteristics and classification of colon cancers 
Adenocarcinoma 
The most common type of colon cancer is the adenocarcinoma that originates 
in glands and accounts for 90-95 % ofall colorectal cancers. About 90% of colorectal 
adenocarcinoma starts as adenomas and theseare which is a type of polyp that may lead 
totumor formation.  Adeocarcinomas in the colon are divided into two types a) mucinous 
and b) signet ring cell type. The mucinous colon tumor comprises about 10-15 of 
adenocarcinomas, whereas the signet ring type represents less than 0.1 % of 
adenocarcinomas [25, 33, 34]. 
About 20% of colon cancers are inherited or are linked to a family history of 
colon cancer. The main types of inherited colon cancers are hereditary nonpolyposis 
colorectal cancer syndrome (HNPCC) and familial adenomatous polyposis (FAP). 
HNPCC or Lynch syndrome is an autosomal dominant genetic condition that increases 
the risk for colon cancer (Figure 4A). [25, 33, 34] HNPCC accounts for 5 7% of all 
colon cancers. HNPCC is featured as \early-onset of colon cancer and is characterized by 
defective mismatch repair genes [35-37]. Another inherited colon cancer is familial 
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adenomatous polyposis (FAP), which develops in childhood and is characterized by 
development of hundreds to thousands of polyps in the gastrointestinal tract. 
Leiomyosarcomas 
Leiomyosarcomas are a type of colon cancer that develops in the smooth 
muscle of the colon. It accounts for less than 2% of colorectal cancers and has a higher 
chance of metastasizing [25, 33, 34]. 
Lymphomas 
Colorectal lymphomas are a less common form of colon cancer which  initiate 
in the rectum then move to the colon. However, if lymphomas develop in the other part 
of the body, this spread to the colon and then move to the rectum. Non-Hodgkin’s 
lymphoma accounts for 0.5% of  all colorectal cancers. [25, 33, 34]. 
Melanomas 
Melanoma colon cancer generally develops from a melanoma that started in 
some other distal organ and then spread to the colon or rectum. Melanoma colon cancer 
is not common and accounts for less than 2% of colorectal cancers. [25, 33, 34].  
Risk factors of colon cancer 
Genetics and specific mutated genes 
FAP can lead to hereditary colon cancer. FAP patients develop colon polyps at 
an early age and gradually develop hundreds of polyps in the colon. The gene involved 
in this disease is called Adenomatous polyposis coli (APC) and if not treated at the early 
stage these polyps can develop into cancer.   
 21 
 
HNPCC, or Lynch syndrome paitents also occurs at an early age andPolyps 
develop in HNPCC to a much lesser extent than in FAP. Mutations in one of the DNA 
repair enzyme genes such as MutL homolog 1, colon cancer, nonpolyposis type 2 
(MLH1),  DNA mismatch repair protein Msh2 (MSH2), MSH6 or mutS homolog 6 
(MSH6), PMS1 protein homolog 1 (PMS1), or mismatch repair endonuclease PMS2 
(PMS2) can lead to hereditary nonpolyposis colorectal cancer (HNPCC) [25, 34].  
According to Kinzler and coauthors APC gene functions as the “gatekeeper” of 
epithelial cell proliferation in colon. Generally, gatekeeper genes play an important role 
in maintaining  cell numbers and  mutation of the gatekeeper gene is responsible for an 
imbalance between cell proliferation and cell death [34]. 
The multi-hit hypothesis has shown that about 4-10 mutational events are 
required for the development of malignant tumors. As for example, events such as 
mutations in APC and p53 (two alleles) and also in one copy of the RAS oncogene 
(Figure 5) may result in colorectal adenocarcinoma [38]. The multi-hit hypothesis is 
common in many cancers where development of preneoplastic cells and tumors growth 
occur due to clonal expansion regulated by successive mutation. First mutation leads to 
limited growth of the cells followed by the second mutation resulting in benign growth 
of the cells. Finally if one of the cells undergoes third mutation results in transformation 
of these cells into a malignant invasive cancer cells [38]. 
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Figure 5 Five hits hypothesis for development of colorectal cancer [38] 
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Environmental and dietary factors  
Environmental factors, specifically diet, play a crucial role in the incidence of 
colorectal cancer [39]. Intake of sucrose or being tall or obese increases the risk for 
colon cancer [39]. High sucrose intake is an important factor in contributing to  
colorectal cancer [39]. Uncooked sucrose increased aberrant crypt loci formation and 
upregulated colonic epithelial cell proliferation in mice.[40]. Studies have shown that 
cooked sucrose may be genotoxic and a common side-product of the cooking process is 
5-hydroxymethyl-2-furaldehyde, a compound that may cause the formation of 
microadenoma [41, 42]. 
Although several studies have been conducted investigating the correlation of  
sucrose intake and the incidence of colon cancer, no significant correlation has been 
observed [43] [39, 42]. The intake of red meat and fat increases the risk of colon cancer. 
Fat intake increased the formation of bile acids and the bowel mucosa is exposed to the 
toxic effects of bile acids. Levels of carcinogenic heterocyclic amines (from red meat 
proteins) are increased in a high fat diet and cooking food such as meat at high 
temperature also increases the amount of heterocyclic amine formation. A significant 
correlation between the intake of red meat and the incidence of colon carcinogenesis  
was observed in several studies [39, 42]. 
 Epidemiological, studies suggest that a diet rich in polyphenolics may protect 
against colonic inflammation and colon cancer [44-46]. Clinical and preclinical studies 
have reported that polyphenolics from pomegranate exert anti-carcinogenic, anti-
inflammatory and antioxidant activities [47-50].  
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Polyphenols 
The large group of polyphenols is the most abundant and ubiquitous group of 
plant secondary metabolites and constituent of the human diet and is comprised of 
several structurally distinguished subgroups. In plants, polyphenols protect the plants 
from pathogens and environmental hazards. Polyphenols are the most important 
compounds mainly produced to defense against UV radiation, pest and predators [9, 51].  
Polyphenols also play an important role in the maintenance of plant physiology, 
morphology, growth and development.[52].  
Sources of polyphenols 
Polyphenols are widely distributed across plant species. Polyphenols belong to 
a diverse group characterized by the presence of phenolic group and also classified by 
their source of origin, chemical structure and biological function. These highly diverse 
and widely distributed polyphenols are plant based and are mainly abundant in fruits 
vegetables, spices  chocolate, coffee, tea, wine and grain [9, 51].       
Biosynthesis and chemistry of polyphenols 
More than 8000 polyphenolic compounds have been identified [52]. The 
Shikimate and acetate pathways are the main two pathways involved for the origin of 
secondary plant metabolite polyphenols. Polyphenols occur as simple molecules such as 
phenolic acid or as polymerized compounds such as tannins. The polyphenols can 
conjugated with one or more sugar such as monosaccharide, disaccharides or 
oligosaccharides linked with hydroxyl groups. Polyphenols either linked with glucose or 
other residues such as galactose and also glucuronic acid. Accordingly polyphhenols are 
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divided into different classes such as simple phenols, benzoquinones, phenolic acid, 
acetophenones xanthones, stilbenes, flavonoids, lignins etc [9] (Figure 6, Figure 7).  
 
 
Figure 6 Schematic overview of acetate and shikimate pathway [52] 
 
 
 
The most common low molecular weight phenolic compounds identified are 
simple phenolic acids with typically one ring flavonoids that contain three benzoic rings. 
Simple phenolics with C6 structure includes phenol, thymol hydroquinone etc. Phenolics 
with (C6- C1) structures including phenolic acid such as gallic acid, p-hydroxybenzoic. 
Among many others, the most important phenylpropanoid are the hydroxycinnamic 
acids such as caffeic acid Ferulic acid and derivatives [9]. The most important plant 
phenolics identified as flavonoids (C6- C3- C6). Based on the basic structure flavonoids 
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forms an oxygenated heterocyclic where two aromatic rings linked though three carbon 
atoms [9].  
 
 
 
Figure 7  Flavonoid classes biosynthesis pathways [52] 
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Figure 8 The basic structure of flavonoids[52] 
 
 
 
The flavonoid ring A is derived from the acetate pathway and ring B is 
originated from the shikimate pathway [9] (Figure 8). 
Flavonoids and simple phenols comprise the major class of plant polyphenols. 
Based on their chemical structure some of the plant phenolics can be linked to the cell 
wall components such as polysaccharides and lignin. Flavonoids mainly exist as free 
monomers. Among the other flavonoids anthocyanins is highly water soluble and 
responsible for plant pigmentation which gives bright color to flowers and fruits. The 
glycosides of anthocyanidin (eg cyanidin, delphinidine etc) are referred by the term 
anthocyanin [9].  
Classification of dietary polyphenols 
Secondary plant components are ubiquitous in plants have been used 
throughout times for medicinal purposes and many are known to be pharmacologically 
safe and [52] effective. Polyphenols have drawn great attention due to the potential to 
reduce various diseases including cardiovascular disease, cancer, and diabetes.  
The more than 8000 polyphenols have been grouped as follows Flavonoids 
including flavonlos (e.g. quercetin), flavones (e.g. apigenin),  flavanol (e.g..epicatechin) 
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flavanones (e.g. naringenin) and anthocyanidines (e.g. Cyanidin) present in 
pomegranate, berries, tea, parsley, soyabean (Table 2 and Table 3) and other 
polyphenols were also identified in turmeric (curcumin), Pterostilbene (blueberries), 
Resveratrol (red wines) (Table2) . Generally, most of the flavanoids identified exist as 
glycosides conjugated with different sugars or polymerized with other polyphenolics 
[53]. 
Flavanoids  
These groups are mainly predominant in plants. As mentioned in the literature 
about 2000 naturally occurring flavonoids were identified. Flavonoids groups were 
classified into following classes’ flavonlos, flavones, flavanols, flavanones and 
anthocyanidines. Flavonols (e.g. quercetin, kaempferol), flavones (e.g. apigenin) along 
with their glycosides comprises the most common flavonoid group (Table 2).  
Flavonol quercetin: The main flavonol available in human diets is quercetin (3, 
5, 7, 3 ‘4’ pentahydroxyflavone), (9).  It is widely distributed in various fruits and 
vegetables, particularly in citrus fruits, apples, onions, parsley, dark berries. Quercetin is 
one of the major bioactive compounds found in fruits such as apple, berries, and wine 
[53]. 
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Table 2 Polyphenols grouped under flavonoids, different classes, compounds and dietary sources [53] 
 
Table 3 Polyphenols grouped carotenoids under different compounds and dietary sources [53] 
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Figure 9 The basic structure of quercetin [51] 
 
 
 
Flavones apigenin: The natural occurring flavones present in the human diet 
are apigenin (4’,5,7-trihydroxyflavone) (Figure 10). Apigenin available in fruits and 
vegetables such as grapefruit , parsley, onions, oranges [54]. 
 
 
Figure 10 The basic structure of apigenin [51] 
 
 
 
Flavanol catechins:  The flavanols catechins (Figure 11) and epicatechins, their 
gallate esters comprises the major constituent of green tea (Figure 12). Three hydroxyl 
groups (OH) groups are arranged adjacently on the B ring of flavonoids to form their 
gallos [55].  
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Figure 11 The basic structure of -(+) -catechins [51] 
 
Figure 12 Tea polyphenol [56-58] 
 
 
 
Flavanone naringenin: The main flavanone available in human diet is 
naringenin (Figure 13) an available in orange peel, involved detoxifying phase II 
enzymes; it induces apoptosis in several cancer cells and also HaCaT p53-mutant human 
keratinocyte cells [59].  
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Figure 13  The basic structure of naringenin [51] 
 
 
 
Anthocyanidins: Anthocyanins are an abundant group of flavonoids (Figure 14) 
present in several fruits and vegetables such strawberries, cherries pomegranate, red 
cabbage, sweet potato, red radish and other bright color fruits [7]. Different 
anthocyanidin such as cyanidine, delphinidin and pelargonidin comprises the phenolic 
group called flavonoids [7, 60-63]. Structural differences between anthocyanin groups 
depend on the presence of hydroxyl groups and also number, nature and position of the 
sugar-group attached [64]. 
 
 
Figure 14 The basic structure of anthocyanidine [10] 
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Delphinidin, is a major anthocyanidin present in several pigmented fruits and 
vegetables. Delpinidine is a diphenylpropane-based polyphenolic ring structure with 
positive charge in its central ring [7].  Cyanidine (Figure 15a) is another important 
anthocyanidin present in pigmented fruits and vegetables. Delphinidin appeared to have 
stronger biological activity due to the presence of three hydroxyl group in β-ring [7] 
(Figure 15b). Pelargonidin is present in pomegranate (Figure 15c). 
                                
 
Figure 15 The basic structure of a. cyanidine; b. delphinidin and c. pelargonidin [51] 
 
 
 
Other polyphenolic compounds Curcumin, Resveratrol and Pterostilbene 
Besides flavonoids other dietary flavonoids compound exists in fruits, vegetables and 
spices shows health benefits (Figure 16). 
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Figure 16 The basic chemical structures of (a) Curcuminoids curcumin (Diferuloyl methane) (b) 
Demethoxy Curcumin (p-Hydroxy-cinnamoyl-feruloyl-methane) (c) Bisdemethoxy Curcumin (p-
Didydroxy-dicinnamoyl-methane) [6, 8, 65] 
 
 
 
Curcumin  Curcumin (diferuloylmethane) derived from the root of Curcuma 
longa L. (Figure 16) basic chemical structure Curcuminoids curcumin (Diferuloyl 
methane, Demethoxy Curcumin (p-Hydroxy-cinnamoyl-feruloyl-methane) and 
Bisdemethoxy Curcumin (p-Didydroxy-dicinnamoyl-methane) mainly used as spices. 
Resveratrol Resveratrol (3,4’,5-trihydroxy-trans-stilbene), a phytoalexin exists 
in two isoform trans- resveratrol and cis- resveratrol (Figure 17) has been shown to 
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exhibit a wide range of medicinal and  biological properties [8]. Resveratrol is found in 
grapes, red wine etc. Resveratrol is absorbed in human liver as resveratrol- glucuronide. 
Trans- resveratrol is known to be more stable form. 
 
 
Figure 17 The basic chemical structure of resveratrol (a) trans- resveratrol and (b) cis-resveratrol[53] 
 
 
 
Pterostilbene It is a natural dimethylated analogue of resveratrol derived from 
blueberries and grape. The chemical structure is trans-3,5-dimethoxy-4’-hydroxystilbene 
(Figure 18).  
 
                 
Figure 18 The basic chemical structure of Pterostilbene [53] 
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In vitro and in vivo studies showed that pterostilbene suppresses tumor growth 
and metastasis without toxicity. Pterostilbene shown much higher bioavailability 
compared to other stilbene compounds. However the molecular mechanism of 
pterostilbene and its effects in humans are not well understood [66]. 
Polyphenols in pomegranate, mango and plum 
Pomegranate  
Pomegranate (Punica granatum L.) which is found mainly in the Mediterranean 
region, India and China, is rich in polyphenols. Pomegranate fruit have been historically 
used for medicinal purposes. It has drawn attention due to its potential health benefits 
that have been demonstrated in several studies [53, 67-69]. Some of the most important 
biochemical components of pomegranate are hydrolyzable tannins ellagitannins, such as 
punicalagins and punicalins, and flavonoids (Figure 19). Polyphenols in pomegranate 
can be consumed in the form of whole fruits, dietary supplement or juice[69].  
Predominant and therapeutically relevant compounds present in pomegranate, 
other than ellagic acid and hydrolysable tannins ellagitannins, are the flavonoids 
anthocyanins delphinidin, cyanidin, and pelargonidin; conjugated 3-glucosides/3,5-
diglucosides such as pelargonidin 3-glucoside, cyanidin 3-glucoside, delphinidin 3-
glucoside, pelargonidin 3,5-diglucoside, cyaniding 3,5-diglucoside, and delphinidin 3,5-
diglucoside (Figure 20) [70]. Ellagitannins (ETs) (Figure 21) are the most common 
polyphenols found in pomegranate and are also available in other berry fruits such as red 
raspberries, black raspberries, strawberries, muscadine grapes, and some nuts [69].  
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Figure 19 Chemical structure of polyphenols presents in pomegranate ellagitannins, punicalagins and 
punicalins, free ellagic acid and anthocyanins [53] 
 
 
Figure 20 Chemical structure of anthocyanins presents in pomegranate (a) pelargonidin 3-glucoside, (b) 
cyanidin 3-glucoside (c) delphinidin 3-glucoside (d) pelargonidin 3,5-diglucoside, (e) cyaniding 3,5-
diglucoside, and (f) delphinidin 3,5-diglucoside) [53] 
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Figure 21 Chemical structure of punicalagin the hydrolysable tannins [53] 
 
 
 
Mango 
Mango (Mangifera indica L.)  is a worldwide consumed tropical fruit.  Mango 
pulp, peel and seeds are rich in bioactive compounds (Figure 22). The most predominant 
and therapeutic compounds present in mango are gallotannins, gallic acid, galloyl 
glycosides and flavonoids such as quercetin and kaempferol glycosides. Mango extract 
also contains mangiferin and complex mixture of other antioxidant polyphenols [71, 72]. 
Ripe mango contains the highest amount of gallic acid content and polyphenolics 
compared to other fruits.  
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Figure 22 Chemical structures of gallotannins the hydrolysable tannins [53] 
 
 
 
Plum 
In plums, therapeutically relevant compounds are flavonols, (the flavan 3-ols 
catechin, and epicatechin; the flavonols quercetin 3-glucoside), anthocyanins (cyanidin 
3- galactoside, 3- glucoside, 3- rutinoside, and 3-acetylglucoside), procyanidins (dimers 
and trimmers), phenolic acids (chlorogenic acid and neo-chlorogenic acid) and 
carotenoids [73-75] (Figure 23). 
 
 
Figure 23 Chemical structures of (a) chlorogenic and (b) neo-chlorogenic acid presents in plums 
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Pharmacokinetics of polyphenolics 
In general, polyphenolics are poorly absorbed in animals and humans as 
indicated by several absorption and bioavailability studies and this presents a limitation 
to their efficacy in animal and human clinical trials [76-78].  Pharmacokinetic studies are 
crucial in the evaluation of the efficacy and safety of polyphenolics in chemoprevention 
and chemotherapy [76-78].   
Pharmacokinetics of pomegranate polyphenolics 
Previous studies have shown that the pharmacokinetic profile of ellagic acid 
indicated limited absorption and rapid elimination after oral administration of 
pomegranate polyphenols [76, 77].  Seeram et al., have shown that with intake of 180mL 
pomegranate juice containing 318 mg punicalagins and 12 mg of free ellagic acid (EA), 
EA concentration were increased in the plasma and cleared from the plasma within 5h. 
The pharmacokinetic profiles of the EA are shown in Figure 24[77].  
 
 
Figure 24 Pharmacokinetic profile of ellagic acid (EA) from pomegranate juice [77] 
The process of absorption, metabolism, distribution, and excretion (ADME) of 
ellagitannins, punicalagins rich pomegranate has been studies in animals and in humans 
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[79-81]. Dietary polyphenols when interfered with the carcinogenesis process either 
interact with phase-I reacted and suppress it or activate phase-II reaction and detoxify 
the carcinogens forming conjugates of phase-I metabolites. Thus the balance between 
carcinogen activating enzyme and detoxifying enzyme determines the interaction of the 
cell to carcinogens. Literature studies have shown that ellagitannin punicalagins rich 
pomegranate juice was absorbed and transformed to ellagic acid and cleared from the 
circulation rapidly.  
Absorption of anthocyanin remains unmodified and can be uptake by cultured 
cells both in cytoplasm or membrane [82] [7]. In vitro and in vivo studies didn’t reveal 
the formation of anthocyanin residue after treatment [7]. However, pharmacokinetics 
studies have shown that in human the bio absorption value of anthocyanin is generally 
poor. 
The absorbed pomegranate polyphenols undergo metabolism and detoxification 
regulated by phase II enzymes such as glucuronosyl transferases and sulfo-transferases 
that increased water solubility. Less water soluble metabolites were also formed by 
enzyme such as catechol-O-methyl transferase (COMT). The activity of these 
metabolizing enzymes depends upon its gene expression [76, 77, 83-85]. The 
metabolities of pomegranate polyphenols were ellagic -acid,  dimethylellagic acid 
glucuronide, urolithin A , urolithin B were identified [76, 77].   
Pharmacokinetics of mango polyphenolics 
The most important and therapeutic compound polyphenols present in mango 
are gallotannins, gallic acid, galloyl glycosides and flavonoids such as quercetin and 
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kaempferol glycosides. Higher molecular weight gallotannins rich mango juice is 
absorbed and transformed to gallic acid [86, 87]. Previous studies have emphasized the 
hydrophilic composition of mango plyphenolics which are more compatible with cell-
based assays and may have a higher bioavailability as opposed to hydrophobic 
compounds [86, 87]. 
Pharmacokinetics of plum polyphenolics  
Previous studies have shown the pharmacokinetics study of chlorogenic acid 
after intravenous administration [88]. The antioxidant and antitumorigenic properties of 
chlorogenic acid and caffeoylquinic acid derivatives have been demonstrated in vitro and 
preclinical studies. In order to emerge as an effective chemopreventive and 
chemotherapeutic agent, chlorogenic acid neo-chlorogenic acid and caffeoylquinic acid 
rich plum juice need to be absorbed and metabolized. Pharmacokinetics studies 
demonstrated a quick absorption and rapid distribution of chlorogenic acid followed by a 
slow elimination [89]. In human clinical trials, it has been found that chlorogenic acid is 
differently absorbed, distributed, metabolized and eliminated (ADME) [90]. 
Polyphenols in cancer prevention and treatment 
In addition to conventional therapies there is a need to develop novel 
therapeutic agents in the prevention and treatment of cancer [91-93]. In order to improve 
therapy success and survival rates it is crucial to develop novel therapeutic agents in 
addition to conventional treatments. Diet containing polyphenol that are present in 
vegetables, fruits, spices, green tea play a crucial role in the prevention of cancer. 
Dietary polyphenols are known to prevent carcinogenesis, inhibit cancer growth and 
 43 
 
suppress transformation, inflammatory process, angiogenesis and metastasis in vitro and 
animal studies [5, 94]. Epidemiological and experimental studies illustrate the anti-
tumorogenic, anti-inflammatory and anti-proliferative effects of a polyphenol-rich diet 
including cruciferous vegetables, curcumin, grapes, pomegranates that all contain 
complex mixtures of polyphenols[5, 94]. 
Polyphenols have drawn some attention due to their chemopreventive 
properties and chemotherapeutic potential without side effects that are known from 
conventional cancer therapeutics [52]. In addition to their potential as anti-cancer, anti-
oxidant, anti-inflammatory agents in the treatment of hypertension, cardiovascular 
disease, cancer, diabetes and others it is also used in the industries such as cosmetics, 
paints, food industry as additive agents [9]. The nutritional significance of natural 
polyphenols such as flavonoids, tannins and other small polyphenols in the 
epidemiological, preclinical and clinical trials for the prevention and treatments of 
chronic diseases such as cancer has been demonstrated [45, 46, 93, 95]. Polyphenols are 
known to interact at the tumor initiation, promotion and progression level (Figure 25) 
[52]. 
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Figure 25 Polyphenolics interaction with multistage carcinogenesis process [52] 
 
 
 
Polyphenols and their targeted molecular mechanism 
Several studies are demonstrated that many classes of polyphenols alter signal 
transduction pathways by modulating the expression of key element involved in cell 
proliferation, apoptosis, differentiation, inflammation as well as angiogenesis and 
metastasis [52]. In cancer cells, the presence of excess reactive oxygen and nitrogen 
species such as hydrogen peroxide (H2O2), hydroxyl radical (-OH), superoxide (O2-), and 
peroxynitrite (ONOO-) oxidative stress is increased [52].  According to several reports, 
the production of H2O2 can inhibit cell apoptosis, increase cell proliferation, 
angiogenesis, invasion and metastasis [52]. In general, cancer cells have a higher 
expression of H2O2 and this may contribute to malignant transformation by inducing 
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damage to DNA, proteins, and lipids, and this may contribute to uncontrolled cell 
proliferation [52]. 
Polyphenolic compounds modulate multiple molecular and cellular pathways 
inhibitingcarcinogenesis. Cell signaling kinases including MAPK, Phosphatidylinositol 3 
kinase PI3K/AKT have been identified targets of several dietary polyphenols [69, 96-
100].  
Polyphenols have been demonstrated to act on transcription factor such as 
NFκB, Specificity protein (Sp) Sp1, Sp3 and Sp4, STAT’s [101]. It also interfere cell 
cycle protein CDK’s and Cyclins and apoptotic proteins such as Caspases, Poly (ADP-
ribose)-polymerase1 (PARP), Bax. In addition polyphenols also targets anti-apoptotic 
marker such BCL-2, survivin and cell proliferation, angiogenesis and metastasis markers 
such as Ki-67, PCNA, iNOS, Cox-2, VEGF, CD-31 and MMPs are also identified as 
dietary polyphenols targets [101].  
In order to understand the pathogenesis of cancer and to inhibit tumor 
development it is important to identify the gene involved and the interference of various 
dietary polyphenols at different molecular and cellular level. Thus polyphenols decrease 
DNA damage, increase detoxification of carcinogenesis at tumor initiation stage, inhibit 
cell proliferation, induce apoptosis and targets various transcription factor at tumor 
promotion stage or finally at progression stage polyphenols decreased expression of 
angiogenic marker, cell adhesion molecules and metastatic marker such as vascular 
endothelial growth factor (VEGF), vascular cell adhesion molecules (VCAM-1) and 
matrix metalloproteinases (MMPs) respectively (Figure 25).  
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Polyphenols possess the ability to inhibit precancerous and cancerous cells. 
Studies presented here investigated polyphenols from whole fruit pomegranate, mango 
or plum that are known to target several cells signaling pathway. Overall, the effects of 
pomegranate extract in miR-27a-ZBTB10-Sp and miR-155-SHIP1- PIP3-AKT-NF-kB 
interactions were investigated. Interactions of Pg with miR126/VCAM-1 and 
miR126/PI3K/AKT/mTOR axes were identified as the underlying mechanisms. Mango 
polyphenols targeting AKT/PI3K/p85 pathway and interactions of PL with 
thePI3K/AKT/mTOR axis were also investigated in this work (Figure 26). 
  
 
Figure 26 Schematic representation of polyphenols modulating several cells signaling pathway  
 
 
 
Cytotoxic activities of polyphenols from fruits presented in this study 
Previous studies have demonstrated that whole fruit polyphenols 
synergistically exhibit stronger anticancer, anti-inflammatory and anti-oxidative 
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properties in comparison to single compounds. In this work, we have presented a study 
of the therapeutic application of three different whole fruits, namely pomegranate, 
mango and plum. Diet consumed by humans with natural polyphenols antioxidants 
compounds has drawn immense attention for its chemopreventive and chemotherapeutic 
agents. Among many others, whole fruit juice and extract were commonly used in 
ancient times for various medicinal purposes [102]. The antioxidant properties of 
pomegranate juice have been found to be similar that of green tea and significantly 
higher than that of red wine [103]. 
Studies have shown that polyphenols is a potent inhibitor of cell proliferation 
in human breast, prostate, liver, lungs and colon cancer [69, 104-110]. The main 
objective of this study is to understand the underlying molecular mechanisms of the 
effect of whole fruit polyphenol extracts on breast cancer cells and on colon cancer. It 
has been shown that the polyphenol compounds reduce cancer risk, cardiovascular and 
several other chronic diseases. However, little research has been conducted to investigate 
the mechanism behind the efficacy of whole fruits. Compared to whole fruit 
polyphenols, individual isolated compounds appears to be less effective, as they remain 
at high levels than their actual appearance in plasma after consuming whole fruits [86, 
87, 111].  
We have investigated the pharmacological and molecular mechanism of 
Pomegranate whole fruit polyphenols and its beneficial effects. Pomegranate is 
consumed as fresh fruit, fermented juice, jam, wine, oil and also in extract supplements 
[102, 103]. The fruit is primarily cultivated in India, China, Afghanistan, Japan and 
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some parts of the United States. Pomegranate polyphenols (Pg) are a rich source of 
polyphenolic compounds including ellagic acid in its free and bound forms and 
hydrolyzable tannins such as, punicalagin and penicillin. These have been demonstrated 
to have beneficial effects in the treatment of several chronic diseases such as cancer and 
cardiovascular diseases [49, 69, 103, 110, 112].  
Pomegranate polyphenols exert powerful antioxidant, anti-inflammatory, and 
anticarcinogenic activities in vitro and vivo [47, 48, 50, 113]. The most abundant among 
these polyphenols is punicalagin the hydrolysable tannins a strong bioactive constituent 
responsible for more than 50% of the pomegranate potent antioxidant and 
anticarcinogenic properties.[114] 
It has been reported that Pomegranate polyphenols has a higher antioxidant 
capacity than both red wine and green tea [103]. Polyphenol rich dietary supplement 
Pomegranate juice scavenges free radicals and decreases macrophage induced oxidative 
stress, lipid peroxidation and antherogenesis in animals [115-118]. Several studies have 
demonstrated the anti-inflammatory effects of Pomegranate juice in atherosclerotic mice 
model [112, 119, 120].   Pomegranate wine is also known to prevent the activation of 
NF-kB in vascular endothelial cells [121]. Literature studies have shown that 
pomegranate polyphenols modulates several pathways in cancer models [47, 49, 50, 69, 
104, 106, 108, 109, 122] 
Commercial pomegranate juice exhibits potent antioxidant and 
antiatherosclerotic [103, 123-126] properties. Punicalagin is the most predominant 
polyphenols present in the fruit husk and during processing. Punicalagin is present in 
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pomegranate juice and is significantly more than 2 g/L concentration[103]. Single 
compound such as ellagic acid and tannins have been shown to possess anticancer 
properties, such as apoptotic, cell cycle arrest properties and suppression of tumor 
growth in animal models [127]. Recently, several studies have demonstrated the effect of 
pomegranate polyphenols on xenografts tumor growth, apoptotic, angiogenic, 
antiproliferative properties and suppression of nuclear factor- kB (NFkB ) activity [47, 
67, 69, 70, 95, 105, 106, 109, 119, 128-131].  Several preliminary data on the NFkB 
pathway targeted by pomegranate polyphenols have been shown but the exact molecular 
mechanism is still unknown. The findings however are consistent with other plant 
polyphenols such as red wine Resveratrol, green tea catechins, curcumin and betulinic 
acid, all of which exhibit antiproliferation and induce apoptosis by modulating NFkB 
pathways [132-139]. 
In this study our objective is to understand the modulation of NFkB and several 
cell signaling pathways in cancer models treated with whole fruit polyphenols (Figure 
27). Nuclear factor-κB (NF-κB), a transcription factor plays a key role in the regulation 
of several genes important in cellular activity such as inflammation, cell growth, and 
progression. There is evidence that the specificity protein (Sp) transcription factors (Sp1, 
Sp3, Sp4), are overexpressed in tumors leading to the proliferative and the angiogenic 
phenotype associated with cancer cells and also induce inflammation by interacting with 
the p65 unit of NF-kB [50, 135, 138-141]. Several botanicals have been shown to 
interact with the specificity proteins, and Sp-repressor zinc finger protein ZBTB10, thus 
inhibiting cancer cell growth in vitro and in vivo. Specificity proteins regulated several 
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genes are important for angiogenesis, inflammation, and cell proliferation such as 
vascular angiogenic growth factor (VEGF), NF-kB and survivin, [50, 135, 138, 139, 
141] 
Similarly previous studies have demonstrated that pomegranate reduces 
inflammation by inhibiting PI3K dependent phosphorylation of AKT in lung cell lines 
and in vivo thus reducing the activation of NF-kB [69, 106]. Previously, resveratrol and 
quercetin, were demonstrated to reduce NF-kB-involved inflammation as well as induce 
apoptosis [142-145]. The objective of this present work is to understand the post-
transcriptional targets involved in inflammatory and apoptotic pathways in estrogen 
receptor positive (ER+) cancer cells treated with polyphenolics extracted from 
pomegranate (Pg) and additionally in nude mice xenografted with cancer cells focusing 
on the anti-inflammatory and pro-apoptotic pathways involving ZBTB10-Sp 
transcription factor-axis and the PI3K-AKT-axis, both regulating inflammation through 
NF-κB as well as apoptosis.  
We have also investigated the effect of pomegranate polyphenols in colon 
cancer cells and potent carcinogenesis azoxymethane (AOM) induced colon cancer rat 
model.   
Previous studies have shown chemopreventive activity of pomegranate extract 
in colon cancer cells [95]. Pomegranate extract is known to suppress NF-κB activation 
and also down-regulates NF-κB dependent genes involved in proliferation (Cox-2) 
angiogenesis (VEGF), and metastasis (ICAM-1, VCAM-1) of the tumor [69, 106, 138, 
146, 147]. Vascular cell adhesion molecule-1 (VCAM-1) is known to be a prognostic 
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marker for colon cancer study [148-150].  VCAM-1 is a cell-surface glycoprotein that is 
responsible for cell-to-cell interactions. Overexpression of VCAM-1 is observed in colon 
cancer [148-150]. These findings support our hypothesis that pomegranate extract 
inhibits NFκB activation and down-regulates the NFκB dependent gene VCAM-1 
(Figure 27). 
 
 
 
 
 
 
 
 
 
 
 
Figure 27 Schematic diagram of the relationship between inflammations, and apoptosis 
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Mango polyphenols are known to inhibit cell proliferation in several cancer cell 
lines such as colon, lung, prostate and breast, cancer cells [86, 87, 111, 151]. Previous 
studies have shown the antioxidant, anti-inflammatory, antitumorogenic and anti-
proliferative properties of mango extract [86, 87, 111, 151]. In addition several 
literatures showed the potential role of mango polyphenols in modulating several cellular 
signaling pathways in cancer model.   
Previous studies indicated the anti-proliferative, anti-inflammatory and anti-
tumorigenic properties of mango extract [86, 87, 111, 151]. The potential role of 
polyphenols present in mango was shown beyond antioxidant and anti-inflammatory 
properties by modulating several cell signaling pathways in cancer model.   Mg 
modulates NF-κB transcription factor, which regulated genes involved in cell 
proliferation, inflammation, angiogenesis and metastasis in cancer development [96, 
138, 152, 153].  Mango polyphenol, mangiferin, have shown chemopreventive and 
chemotherapeutic action against benzo(a)pyrene induced lung cancer in swiss albino 
mice [154]. Similarly mango polyphenols are also known to reduced prostate cancer in 
mouse and inhibited human prostate LNCaP cell proliferation through apoptosis [111]. 
Previous studies have shown that polyphenolics derived from plums have 
chemoprevention and chemotherapy potential against cancer development. Plum 
polyphenols act as cancer inhibiting agents through scavenging free radicals and 
inhibiting tumor growth. Plum polyphenols suppress tumor development by inducing 
tumor cell apoptosis and by modulating different signal transduction pathways. Several 
literature studies have shown the chemoprevention and chemotherapeutic properties of 
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flavan 3-ols, flavonols, anthocyanins. However, not many studies have been performed 
on phenolic acids such as chlorogenic and neo-chlorogenic, which are known to be less 
potent polyphenols to inhibit cell cycle and induce apoptosis [73-75, 155]. 
Chlorogenic and neo-chlorogenic acids are the esters formed between caffeic 
acid and quinic acid. These compounds have shown a wide range of biological and 
pharmacological activities and have been used as a cancer blocking agent, suppressed 
reactive oxygen species (ROS) mediated inflammation and inhibited cancer growth in 
several cancer models such as azoxymethane (AOM) treated colon cancer, liver, breast, 
oral and tongue cancer [74, 155-161]. Regarding the cancer suppressing properties of 
chlorogenic acid, it targets different molecular pathways for different cancer models. In 
addition, Chlorogenic and neo-chlorogenic acid also acts as a strong antioxidant dietary 
compounds. In vitro, these compounds scavenge free radicals, increase the resistance of 
LDL to lipid peroxidation and inhibit DNA damage[74, 155].         
As previous studies have shown, chlorogenic acid play an important role as an 
antioxidant agent and function as a repressor of metabolic activation of carcinogens. 
Chlorogenic acid also acts as a modulator of intracellular signaling pathways. In vitro 
and preclinical animal studies have established the antioxidant and anticarcinogenic 
activities of chlorogenic acid and neo-chlorogenic acid. 
However, despite the high potential of polyphenolics in cancer prevention and 
treatment efficacy and molecular mechanisms are not conclusively investigated.  Thus in 
the presented research it was the objective to understand the efficacy of polyphenols 
present in pomegranate, mango and plum and underlying molecular mechanisms.
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CHAPTER II 
CYTOTOXICITY OF POMEGRANATE POLYPHENOLICS IN BREAST CANCER 
CELLS IN VITRO AND VIVO - POTENTIAL ROLE OF MIRNA-27A AND MIRNA-
155 IN CELL SURVIVAL AND INFLAMMATION 
 
 
Summary 
Several studies have demonstrated that polyphenolics from pomegranate 
(Punica granatum L.) are potent inhibitors of cancer cell proliferation and induce 
apoptosis, cell cycle arrest, and also decrease inflammation in vitro and vivo. There is 
growing evidence that botanicals exert their cytotoxic and anti-inflammatory activities, 
at least in part, by decreasing specificity protein (Sp) transcription factors.  These are 
overexpressed in breast-tumors and regulate genes important for cancer cell survival and 
inflammation such as the p65 unit of NF-κB.  
Moreover, previous studies have shown that Pg extracts decrease inflammation 
in lung cancer cell lines by inhibiting phosphatidylinositol 3,4,5-trisphosphate (PI3K)-
dependent phosphorylation of AKT in vitro and inhibiting the activation of NF-kB in 
vivo. The objective of this study was to investigate the roles of miR-27a-ZBTB10-Sp 
* Reprinted with permission from “Cytotoxicity of pomegranate polyphenolics in breast cancer cells in 
vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation”, by 
Banerjee N, Talcott S, Safe S, Mertens-Talcott SU, 2012, Breast Cancer Res Treat. 136, 21-34, 
Copyright 2012 by Springer 
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and miR-155-SHIP-1-PI3K on the anti-inflammatory and cytotoxic activity of 
pomegranate extract. 
Pg extract (2.5-50 µg/ml) inhibited growth of BT-474 and MDA-MB-231 cells 
but not the non-cancer MCF-10F and MCF-12F cells. Pg extract significantly decreased 
Sp1, Sp3, and Sp4 as well as miR-27a in BT474 and MDA-MB-231 cells and increased 
expression of the transcriptional repressor ZBTB10. A significant decrease in Sp 
proteins and Sp-regulated genes was also observed. Pg extract also induced SHIP-1 
expression and this was accompanied by downregulation of miRNA-155 and inhibition 
of PI3K-dependent phosphorylation of AKT.  
Similar results were observed in tumors from nude mice bearing BT474 cells 
as xenografts and treated with Pg extract. The effects of antagomirs and knockdown of 
SHIP-1 by RNA interference confirmed that the anti-inflammatory and cytotoxic effects 
of Pg extract were partly due to the disruption of both miR-27a-ZBTB10 and miR-155-
SHIP-1. In summary the anticancer activities of Pg extracts in breast cancer cells were 
due in part to targeting microRNAs155 and 27a. Both pathways play an important role in 
the proliferative/ inflammatory phenotype exhibited by these cell lines. 
Introduction 
Polyphenols from fruits, vegetables and spices have demonstrated anti-
inflammatory and anticarcinogenic activities in vitro and vivo [67, 69, 104, 106, 129, 
130, 138, 162-165] . This includes several reports on the cytotoxic activities of 
polyphenols in the prevention and treatment of breast and other cancer cell lines [8, 67, 
104, 122, 129, 166-169]. Pomegranate (Punica granatum L.) is rich in polyphenols. The 
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predominant and therapeutically relevant compounds are ellagic acid, ellagitannins, 
flavonoids, and 3-glucosides/3,5-diglucosides of the anthocyanins delphinidin, cyanidin, 
and pelargonidin [70], that exert antioxidant, anti-inflammatory, and anticarcinogenic 
activities in vitro and vivo [47, 48, 113]. Polyphenolics from pomegranate juice and 
peels inhibited aromatase activity relevant to the prevention of breast cancer [104, 170] , 
exhibited cytotoxic activities in hepatocellular carcinomas in rats [109], and suppressed 
chemical-induced colon cancer in rats [165, 171]. The inhibition of  NF-κB and other 
inflammatory markers by pomegranate polyphenolics have been reported for breast [104, 
130], lung [69, 106] and prostate cancer cell lines [49, 67, 99]. 
In previous studies, we have demonstrated that the cytotoxicity of several 
botanicals is due, in part, to downregulation of specificity protein (Sp) transcription 
factors (Sp1, Sp3, Sp4). These transcription factors are widely overexpressed in tumors 
and regulate genes required for cell proliferation, survival and angiogenesis [139, 140, 
172-176]. Sp-1 is also involved in the regulation of NF-κB through both a GC-rich 
binding site in the promotor region of the NF-κB p65 subunit and agents such as 
curcumin that downregulate Sp transcription factors also decreased NF-κB [138].The 
high expression of Sp1, Sp3 and Sp4 in breast and other cancer cell lines and the effects 
of botanical drugs on downregulation of Sp transcription factors is due to several 
pathways, including both proteasome-dependent and independent mechanisms [138, 
141]. In breast cancer cells, the high expression of Sp is due, to suppression of ZBTB10, 
a Sp-repressor by miR-27a. It has been shown that several anticancer agents act through 
downregulation of miR-27a which is accompanied by induction of ZBTB10 and 
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downregulation of Sp proteins [138-140, 175-177] and our preliminary screening of 
miRNAs indicated that miR-27a expression was significantly decreased by pomegranate 
extract.  
Previous studies on the anti-inflammatory properties of pomegranate indicate 
that pomegranate extract decreased NF-κB [178] [179]. Our preliminary screening of 
inflammation-involved microRNAs showed that pomegranate extract decreased the 
expression of miR-155 and this was accompanied by induction of the miR-155-regulated 
inositol 5'-phosphatase SHIP-1. This phosphatase is a crucial regulator of 
phosphatidylinositol-3,4,5-trisphosphate (PI3K), a second messenger in the activation of 
AKT and nuclear translocation of NF-κB [180] [181]. Previous studies reported that Pg 
extracts decreased inflammation and repressed lung-tumor growth in mice by inhibiting 
PI3K-dependent phosphorylation of AKT and decreasing  the activation of NF-κB in 
vivo [69, 106]. Moreover, the polyphenols resveratrol and quercetin decreased miRNA-
155 and inhibited NF-κB-involved inflammation in a preclinical murine model and in 
vitro cell study [142, 182-184]. This suggests that pomegranate polyphenolics may act 
through miR-155, SHIP-1 and AKT associated pathway [185].  
Hence, the objective of this study was to investigate the role of miR27a-
ZBTB10 and miR-155-SHIP-1 in mediating the anti-inflammatory and cytotoxic effects 
of pomegranate polyphenolics. 
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Materials and methods 
Botanical extracts 
Stiebs Pomegranate Products (Madera, CA) provided the pomegranate juice 
concentrate (Pg) utilized in this study from the 2009 California crop (Sample # 0622-
33808). Pg was stored at 4°C upon receipt and isolated within 48 h.  Polyphenols from 
Pg were diluted with water to facilitate loading and partitioning from a Sep Pack Vac 20 
g C18 cartridge (Waters Corp. Milford, MA) previously conditioned with 100% 
methanol containing 0.01% HCl.  Compounds were eluted with 100% methanol and 
solvent removed by rotary evaporation  (Büchi Labortechnik AG, Flawil, Switzerland) at 
40°C.  Residual water was removed on a speedvac system (Savant, Thermo Scientific 
Inc, Pittsburgh, PA).  The dried extract was stored at -80°C prior to weighing and 
dissolution in dimethyl sulfoxide (DMSO) for cell culture and analytical procedures.   
HPLC-PDA analysis 
The pomegranate polyphenolics were analyzed in negative ESI-MS and 
quantified against a standard of punicalagins A and B and cyanidin-3-gluoside. 
Separations were made in a SunFireTM C18 column (Supelco Inc. Bellefonte, PA) (250 x 
4.8 mm, 5 µm) at room temperature. A mobile phase of water/acetic acid was run (98:2) 
to Phase A and acetonitrile/water/acetic acid was run (68:30:2) in Phase B. A gradient 
program at 0.4 mL/min initially ran Phase B at 0%, from 0 to 5% Phase B in 1 min, from 
5 to 30% Phase B in 15 min, from 30 to 65% Phase B in 40 min, and 65 to 95% Phase B 
in 50 min before returning to initial conditions. Detection was at 280 and 520 nm for 
ellagitannins and anthocyanins, respectively. Compounds were tentatively identified 
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based on mass spectrometric analysis. This was  performed on a Thermo Finnigan LCQ 
Deca XP Max ion trap mass spectrometer with an electrospray ionization probe in 
negative ion mode under the following conditions sheath gas (N2), 60 units/min; 
auxiliary gas (N2), 5 units/min; spray voltage, 3.3 kV; capillary temperature, 250°C; 
capillary voltage, 1.5 V; tube lens offset, 0 V. Standard compounds for the identification 
and quantitative analysis of ellagitannins and anthocyanins were obtained from Acros 
Organics (Morris Plains, NJ.) and ChromaDex (Irvine, CA), respectively. 
Reagents 
Antibodies against cleaved caspase-3, poly-(ADP-ribose)-polymerase (PARP), 
NF-κB (p65), phosphorylated NF-κB (p65) as well as SHIP-1 were purchased from Cell 
Signaling Technology (Beverly, MA). All other antibodies and SHIP-1 small interfering 
RNA (SiRNA) were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). 
Reporter lysis buffer and luciferase reagent for luciferase studies were obtained from 
Promega (Madison, WI). Invitrogen (Grand Island, NY) supplied LipofectAMINE 2000 
reagent. Western lighting chemiluminescence reagent was purchased from Perkin-Elmer 
Life Sciences (Waltham, MA).  Primers for Sp1, VEGF, VEGFR-1, survivin, ZBTB10, 
SHIP-1 were purchased from Integrated DNA Technologies (San Diego, CA). Primers 
for Sp3 and Sp4 were obtained from Qiagen; antagomers of miR-27a (inhibitor) and 
miR155 (inhibitor), as well as scrambled miRNA were from Dharmacon, Inc. (Lafayette, 
CO). mirVana TM extraction kit, reverse transcription (RT) and real-time PCR 
amplification kits were purchased from Applied Biosciences (Foster City, CA). Sp1, Sp3 
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and NF-κB promoter constructs were kindly provided by Dr. Yanan Tian (Texas A&M 
University). 
Cell culture 
Human mammary carcinoma cell lines BT474 and MDA-MB-231 as well as 
non-cancer breast fibroblasts MCF-10F and MCF-12F, were obtained from ATCC and 
maintained according to the supplier guidelines (American Type Tissue Collection 
(ATCC, Manassas, VA).  
Cell proliferation 
The cell proliferation was assessed with an electronic cell counter at 48 h 
(Z1™ Series, Beckman Coulter, Inc, Fullerton, CA),  as previously described, [139] and 
are presented as net growth.  
Real-time PCR analysis of mRNA and miRNA 
BT474 and MDA-MB-231 cells were seeded (3 x 105 cells onto a 6-well plate) 
and incubated for 24h to allow cell attachment. Cells were treated with Pg extract and 
after 24 h mRNA was extracted for gene expression analysis as previously described 
[139]. RNA-quality and quantity was assessed using the NanoDrop® ND-1000 
Spectrophotometer (NanoDrop Technologies, Wilmington, DE). Reverse transcription 
(Invitrogen Corp., Grand Island, NY) and qRT-PCR were carried out as previously 
described [139] on an ABI Prism 7900 Sequence Detection System (Applied Biosystems 
Inc, Foster City, CA). Primers for TBP, ZBTB10, Sp1, Survivin, VEGF and VEGFR-1 
have been previously described [139]. The primer-sequences for SHIP-1were F:5’-GTG-
GAG-AGA-TCT-GGC-CTC-AG-3’ and  R:5’-GGG-AGC-AAC-AGC-AAA-GAC-TC-
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3’, for VEGF,  the sequence were F:5’- AAG GAG GAG GGC AGA ATC AT-3’, and  
R:5’- ATC TGC ATG GTG ATG TTG GA-3’.  Integrated DNA Technologies, Inc. 
(Coralville, IA). Primers were designed using Primer Express software (Applied 
Biosystems, Foster City, CA), homology-searched by an NCBI BLAST and examined 
by dissociation curve analysis. Primers for Sp3 and Sp4 were purchased from Qiagen. 
microRNA was extracted, reverse transcribed, and qRT-PCR reaction was performed as 
previously performed [139, 140]. 
Transfection with antagomers of miR-155 and miR-27a (inhibitors), miR-27a mimic, or 
small interfering RNA (siRNA) against SHIP-1 gene  
Cells seeded (1x105) into 12-well plates were incubated for 24h to allow cell 
attachment. Transfections with 10nM siRNA against SHIP-1 gene Santa Cruz 
Biotechnology Inc. (Santa Cruz, CA) and antagomers (inhibitors) of 20 nM, 40 nM and 
80 nM  miR-27a and miR-155, and also mimic of 20 nM miR-27a (Dharmacon, Lafay 
ette, CO) were performed  as previously described [138, 139] 
Reporter gene transfection and luciferase assays  
Cells were transfected with constructs as previously described [138, 139, 164].  
Western blotting  
Cells (4 × 105) were seeded in 6-well plates and incubated 24 h to allow cell 
attachment. They were also treated with Pg extract (0-10µg/mL) for 24 h. Cells were 
harvested and prepared for Western Blotting as previously performed [139, 140]. 
Proteins were visualized with a Kodak Molecular Imaging System (Carestream Health, 
Rochester, NY). 
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Xenograft study  
Female athymic BALB/c nude mice (aged 3- 4 weeks) from Harlan laboratory 
(Houston, TX) were implanted with  BT474 cells (2X106 cells) in matrigel (BD 
Bioscience San Jose, CA) s.c into the flank [139].   After 10 days mice were treated with 
either 100 µl vehicles (1% DMSO in corn oil) by oral gavage, or 0.8mg gallic acid 
equivalent (GAE)/kg/day of Pg extract/d for 35 days after approval by the Institutional 
Animal Care and Use Committee at Texas A&M University (College Station, TX). Final 
body and tumor weights were determined. Tissues were flash-frozen in liquid nitrogen 
and stored at -80˚C for mRNA and protein analysis. 4-AM-thick paraffin-embedded 
tumor sections were cut and stained with Hematoxylin and Eosin (H&E) for bright field 
microscopy. 
Statistical analysis. Quantitative data represent mean values with the respective 
standard deviation (SD) or standard error of the mean (SE) corresponding to 3 or more 
replicates. Data were analyzed by one-way analysis of variance (ANOVA) using SAS 
version 9.3 (SAS Institute Inc., Cary, NC). Tukey’s Post Hoc multiple comparisons were 
used (p<0.05) to establish significant statistical difference. 
Results 
Polyphenolic composition of pomegranate extract determined by HPLC-MS 
The polyphenolic profile of pomegranate varieties was previously reported as 
being rich in ellagitannins and anthocyanins [47-49, 103]. The primary ellagitannin in 
pomegranate juice is punicalagin [103], that can be converted into free ellagic acid upon 
hydrolysis. In this study, a polyphenolic extract was prepared from a pomegranate juice 
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extract (Pg) that was kindly provided by Stiebs LLC (Kirkland, WA). The 
chromatographic profiles (Figure 28a and b) show the ellagitannins punicalagin A (peak 
1), punicalagin B (peak 2), anthocyanins delphinidin 3-glucoside (peak 3) and cyanidin-
3-glucoside (peak 4). Low concentrations of ellagic acid glucoside (peak 5) and free 
ellagic acid (peak 6) were also detected.  
Anti-proliferative and pro-apoptotic activities of pomegranate extract  
The cytotoxic activities of Pg were investigated in human BT474 and MDA-
MB-231 breast cancer cell-lines and non-cancer breast fibroblasts MCF-10F and MCF-
12F (Figure 29a).  In both cancer cell lines, there was a concentration-dependent 
decrease in cell viability after treatment with Pg (2.5-25 µg/ml) after 48 h. In contrast, no 
significant cytotoxic effects were observed in non-transformed cells treated under the 
same conditions (Figure 29a). Similar results were observed after 72 h (data not shown). 
Pg-induced cytotoxicity was accompanied by activation of capase-3, a primary 
apoptosis-executing enzyme, and the cleaved product of the substrate Poly (ADP-
ribose)-polymerase1 (PARP) [186]. Full lengths PARP protein was not decreased by Pg 
whereas the highest concentration of Pg decreased full length Caspase-3 (Figure 29b).  
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Figure 28 Representative chromatogram of polyphenolic compounds in an extract of mango juice 
concentrate (a) ellagitannins at 280 nm, tentative peak assignments. 1, punicalagin A; 2, punicalagin B; 5, 
ellagic acid glucoside and 6, ellagic acid; (b) anthocyanins at 520 nm, tentative peak assignments. 3, 
delphinidin-3-glucoside; 4, cyanidin-3-glucoside 
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Figure 29 Pomegranate extract (Pg) inhibited proliferation and induced apoptosis in cancer cells (a) cells 
were seeded and treated with DMSO (vehicle control) or different concentrations of Pg (2.5-10 µg/ml 
treatment) for 48 h. (b) western blot analysis of apoptosis-associated proteins (Full length capase-3 and 
cleaved capase-3; full length PARP and cleaved PARP). BT474 cells were treated with DMSO (control 
vehicle) or different concentrations of Pg extract 2.5-10 µg/ml for 24 h, and whole-cell lysates were 
analyzed by western blot analysis. All experiments were performed as described in the material and 
method section and were performed at least three times, and the result was expressed as mean ± SE. * 
indicates significant changes at p<0.05. 
 
 
Modulation of Sp transcription factors and Sp-regulated genes and disruption of miR-
27a:ZBTB10 
Treatment of BT474 breast cancer cells with Pg (2.5-10 µg/ml) decreased 
expression of Sp1, Sp3, and Sp4 mRNA (Figure 30a) and protein (Figure 30b). Pg  also 
decreased luciferase-activity in BT474 cells transfected with a plasmid construct 
containing the GC-rich regions from the Sp1  and Sp3 promoters [139] (Figure 30c).  
Additionally, Pg induced expression of the Sp-repressor ZBTB10 (Figure 30d) and 
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decreased VEGF, VEGFR-1 and survivin mRNA and protein (Figure 30e) and (Figure 
30f).  [139].  
The basal expression of miR27a was higher in BT474 and MDA-MB-231 
breast cancer cells compared to the non-cancer breast fibroblasts (Figure 30g). Pg (2.5-
10 µg/ml) significantly decreased miR-27a expression only in the cancer cell lines in a 
concentration-dependent manner, in the non-cancer fibroblasts minimal effects on miR-
27a were observed (Figure 30h). When BT474 cells were transfected with the antagomir 
(Ant.) of miR-27a, miR-27a was decreased and ZBTB10 mRNA was induced and this 
was comparable to the effects of Pg extract (Figure 30d and h) Both the miR-27a 
antagomir and Pg extract alone and in combination decrease miR-27a (Figure 30i) and 
induce ZBTB10 (Figure 30j). Transfected of BT474 cells with miR27a mimic increased 
miR-27a level and this was partially reversed by the treatment with Pg, indicating that 
Pg directly or indirectly targets miR27a (Figure 30k). We also observed the Pg extract 
decreased Sp1, NF-κB (p65) and VEGF protein (Figure 31a) and mRNA (Figure 31b) 
expression in MDA-MB-231 cells and this was accompanied by induction of ZBTB10 
mRNA (Figure 31c) and this is similar to the effects of Pg extract in BT474 cell. 
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Figure 30 Effects of Pg on Sp1, Sp3, Sp4 and Sp-regulated genes in BT474 cells Pg extract decreased Sp1, 
Sp3 and Sp4, and Sp-regulated genes and induced apoptosis. Cells were treated with solvent DMSO 
(control vehicle) or different concentration of Pg (2.5-10 µg/ml) for 24h. (a) expression of mRNA and (b) 
protein of Sp1, Sp3 and Sp4. (c) the luciferase activity of Sp1 and Sp3 promoter constructs transfected into 
BT474 cells. The data represent ratios of luciferase/β-gal activity in transfected cells treated with DMSO 
(control) or Pg (2.5-10µg/ml) for 24h. (d) mRNA levels of ZBTB10 of cells treated with DMSO (control) 
or Pg (2.5-10µg /ml) for 24h. (e) Survivin, VEGF and VEGFR-1 mRNA and (f) protein levels of cells 
treated with DMSO (control) or Pg (2.5-10µg /ml) for 24h. (g) miR-27a and (h) miR-27a in different 
breast cancer and non-cancer breast fibroblasts (i) effects of Pg with and without the antagomir (Ant.) for 
miR-27a on the expression of miR-27a, (j) on the expression of ZBTB10 mRNA and (k) Effects of Pg 
with and without the mimic for miR-27a on the expression of miR-27a.  All experiments were performed 
as described in the material and method section and were performed at least three times, and the result was 
expressed as mean ± SE. * indicates significant changes at p<0.05 
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Figure 31 Effects of Pg on Sp1 and Sp-regulated genes in MDA-MB-231 cells (a) expression of protein 
and (b)mRNA of Sp1, NF-κB and VEGF (c) mRNA levels of ZBTB10 in cells treated with DMSO 
(control) or Pg (2.5-10µg /ml) for 24h. All experiments were performed as described in the material and 
method section and were performed at least three times, and the result was expressed as mean ± SE. * 
indicates significant changes at p<0.05. 
 
 
Pg-induced modulation of SHIP-1, PI3K and AKT and involvement of SHIP-1 and miR-
155 in the modulation of AKT and NF-κB 
Pg also induced the upregulation of SHIP-1 mRNA and protein in BT474 
(Figure 32a and b) and this was accompanied by a decrease in pPI3K and pAKT while 
but not AKT (total protein) (Figure 32b). Pg extract also caused similar effects on SHIP-
1, pAKT, pPI3K and AKT in MDA-MB-231 breast cancer cells (Figure 32c).  To better 
understand the effects of Pg on SHIP-1, PI3K and AKT, BT474 cells were transfected 
with the siRNA of SHIP-1. SiRNA SHIP-1 increased pAKT protein levels. In contrast, 
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Pg decreased pAKT protein expression (Figure 32b) and these effects were partially 
reversed by siRNA SHIP-1 (Figure 32d). MiR-155 is overexpressed in several breast 
cancer cell lines [187-190].  It was previously reported that polyphenolic extracts 
decrease miR-155 [142, 182, 191].  Basal expression of miRNA-155 was elevated in 
BT474 and MDA-MB-231 cells compared to the non-cancer cell lines (Figure 32e). Pg 
(2.5-10 µg/ml) significantly decreased miR-155 (Figure 32f) in the cancer cell lines 
(compared MCF-10F and MCF-12F) and this correlates with the upregulation of SHIP-1 
mRNA levels in BT474 and MDA-MB-231 cells (Figure 32a and c). Transfection of 
BT474 cells with miR-155 antagomir of treatment with 10 µg/ml  Pg alone or in 
combination decreased miR-155 expression (Figure 32g) and increased SHIP-1 mRNA  
level (Figure 32h). Further confirming that Pg extract disrupts miR155: SHIP-1 
interaction in BT474 cells. 
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Figure 32 Effects of Pg on AKT-associated kinase pathways in BT474 and MDA-MB-231 cells (a) effects 
of Pg on SHIP-1 mRNA levels and (b) SHIP-1, pP13K and pAKT protein expression in BT474 cells. Cells 
were treated with solvent DMSO (control) or different concentration of Pg (2.5-10 µg/ml) for 24 h (c) 
SHIP-1 mRNA levels and protein expression of SHIP-1, pP13K and pAKT in MDA-MB-231 cells. Cells 
were treated with solvent DMSO (control) or different concentration of Pg (2.5-10 µg/ml) for 24 h (d) 
effect of SiRNA SHIP-1 with and without Pg on pAKT protein (e) basal levels of miR-155 in different 
breast cancer and non-cancer breast fibroblasts. (f) effects of Pg on miR-155 levels in different breast 
cancer and non-cancer breast fibroblasts. (g) effects of Pg with and without Ant. miR155 in BT474 cells 
on the expression of miR155 and (H) SHIP-1 mRNA levels. All experiments were performed as described 
in the material and method section and were performed at least three times, and the result was expressed as 
mean ± SE. * indicates significant changes at p<0.05. 
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Effects of Pg on NF-κB  
Pg significantly inhibited the constitutive expression and phosphorylation of 
NF-κB p65 in BT474 cells (Figure 33a) and in MDA-MB-231 cells was also decreased 
by Pg (Figure 31a) Furthermore, Pg extract decreased luciferase activity in BT474 cells 
transfected with pNF-κB-Luc (Figure 33b) and similar results were observed in cell co 
transfected with miR-155 (Figure 33c) or miR-27a (Figure 33d) antagomirs. These 
results suggest that both microRNAs are involved in Pg-induced repression of NF-κB. 
 
 
 
       
Figure 33 NF-κB expression and activity in BT474 cells (a) effect of Pg on NF-κB and pNF-κB protein 
levels and (b) luciferase activity in a plasmid containing a NF-κB binding site in the luc-promoter region. 
Cells were treated with solvent DMSO (control) or different concentration of Pg (2.5-10 µg/ml) for 24h. 
Effects of (c) miR-155 antagomers (Ant.) and (d) miR-27a antagomers (Ant.) on luciferase activity of the 
NF-κB promoter construct. Luciferase activity is expressed as ratio to β-gal. All experiments were 
performed as described in the material and method section and were performed at least three times, and the 
result was expressed as mean ± SE. * indicates significant changes at p<0.05. 
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Xenograft study in athymic female nude mice  
The clinical relevance of the cytotoxic activities of Pg observed in vitro was 
investigated in an orthotopic model of breast cancer in athymic female nude mice with 
BT474 cells as xenografts. Treatment with Pg (0.8mg GAE/kg/day/) significantly 
decreased tumor volume and weight (Figure 34a and b). Histopathologic evaluations of 
tumors indicated that tumors of Pg-treated animals exhibited with increased apoptotic 
lesions compared to the control group (Figure 34c). Moreover, Pg decreased the 
expression of Sp1, mRNA and Sp1, Sp3, and Sp4 protein level (Figure 34d and e) and 
significantly decreased miR-27a (Fig. 7f) whereas ZBTB10 mRNA was upregulated 
(Figure 34d). In addition, Sp-regulated genes including VEGF, survivin and NFkB p65 
were also decreased at the protein and mRNA level in tumors from mice treated with Pg 
compared to the control tumors (Figure 34d and e).In addition SHIP-1 mRNA (Figure 
34d) and protein (Figure 34e) levels were induced in tumors.  This was accompanied by 
a reduction of SHIP-1-regulated proteins pAKT and pPI3K in mice exposed to Pg 
(Figure 34e) and miR-155 (Figure 34f) was also decreased. 
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Figure 34 Antitumorigenic activity of Pg extract in vivo (a) in vivo studies athymic nude mice (10 per 
group) bearing BT474 cells as xenografts were treated with corn oil (control) or Pg extract in corn oil (0.8 
mg Gallic Acid Equivalent (GAE)/kg/day) every day as described in the materials and methods reduced 
the tumor size, tumor area (b) and tumor weights (c) were determined as described in material and method 
section. (d) Histopathologic evaluation of tumors. Tumor from corn oil (control) and Pg extract treated 
mice were fixed, stained with hematoxylin and eosin (H&E) and examined histopathologically as 
described in the material and methods section. Pg extract decreases Sp- regulated genes and induces 
apoptosis in tumors. (e) effect of Pg on SHIP-1, Sp1, survivin, VEGF and ZBTB10 mRNA levels. (f) 
effect of Pg on Sp1, Sp3 and Sp4, VEGF survivin (Sp-dependent genes) and SHIP-1, pAKT, pPI3K and 
NF-kB protein levels. (g) in-vivo results showed miR-27a and miR-155 expression were significantly 
reduced in dosed (Pg treated) mice than the control. All experiments were performed as described in the 
material and method section and were performed at least three times, and the result was expressed as mean 
± SE. * indicates significant changes at p<0.05.
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Discussion 
This study has investigated the cytotoxic and anti-inflammatory activities of a 
pomegranate extract in breast cancer cells and in an animal model [104, 165, 170]. Pg 
decreased breast cancer cell growth, and tumor volume and activated caspase-3). 
Polyphenolic pomegranate has previously been shown to induce apoptosis in cancer cell 
lines including breast, prostate, liver, lung and skin cancer involving multiple pathways 
and inducing apoptosis involving caspase-3 [69, 102, 104, 106, 109, 186]. Previous 
studies have observed resistance of non-cancer cells to the effects of polyphenolics 
observed in this study has been previously reported with delphinidin (anthocyanin) from 
pomegranate extracts [104, 192, 193]. The effects of Pg extracts on inhibition of tumor 
growth in anthymic nude mice bearing BT474 cells as xenografts has also been observed 
in nude mice bearing prostate, pancreatic and breast cancer cells [69, 138, 139, 163, 
175]. 
Sp transcription factors (Sp1, Sp3, Sp4) that are overexpressed in multiple 
tumors and regulate genes required for cell survival and angiogenesis and it has been 
reported that the suppression of Sp transcription factors results in growth inhibition and 
apoptotic cell death [138, 140, 175]. Overexpression of Sp in cancer cell lines and tumor 
is usually accompanied by upregulation of genes involved in cell survival, growth 
promotion and angiogenesis [139, 140]. In this study, Pg extract decreased Sp1, Sp3, and 
Sp4 mRNA as well as protein levels and also decreased Sp-regulated genes involved in 
cell proliferation, angiogenesis and inflammation, namely cyclin D1, bcl2, survivin 
VEGF and its receptor (VEGFR-1) and NF-κB.These results are consistent with 
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previous reports, where secondary plant compounds,  such as curcumin and a 
pentacyclic triterpene betulinic acid , decreased Sp1, Sp3 and Sp4 and  Sp-dependent 
genes [138-140, 175] . We previously investigated the regulation of Sp transcription 
factors  by microRNA-27a, that is also overexpressed in breast cancer and other cancer 
cell lines [139, 140, 176, 194, 195]. A specific antagomir for miR-27a (as-miR-27a) 
increased the expression of ZBTB10, a zinc finger protein [139, 140, 176] that in turn 
suppresses Sp and Sp-dependent mRNA/protein expression [139, 140]. The regulation of 
Sp and Sp-dependent genes through the miR27a-ZBTB10-Sp-axis by both botanical 
compounds and synthetic derivatives, has been shown in cancer cells and tumors derived 
from multiple sites [139, 164, 175, 176, 195, 196].  Pg also significantly decreased miR-
27a in breast cancer cells, but not in non-transformed cell lines and upregulated ZBTB10 
mRNA expression in BT474 and MDA-MB-231 cells. When cells were transfected with 
the antagomir of miR-27a, the expression of miR-27a was decreased and mRNA of 
ZBTB10 increased where Pg further enhanced as-miR27a-induced effects. This indicates 
that miR-27a-ZBTB10-Sp is involved in the Pg-induced downregulation of NF-kB and 
genes involved in survival and angiogenesis. Moreover, when cells were transfected with 
the mimic of miR-27a, the effects of Pg, were reversed by the mimic indicating that Pg 
either directly or indirectly targets miR-27a. Previous reports indicate that botanicals 
decreased miR-27a expression however, this has not been confirmed for a complex 
polyphenolic extract [139] [176, 196].  Results observed in athymic female nude mice 
study correspond to the in vitro studies where miR-27a was decreased and ZBTB10 was 
increased by the treatment of mice with Pg.  
  
76 
 
Pg extracts decreased luciferase-activity in BT474 cells transfected with pNF-
κB-Luc indicating a decrease of overall NF-kB activity and a miR-27a, antagomir also 
decreased luciferase activity in BT474 cells transfected with pNF-κB-luc , confirming a 
role of this microRNA in Pg-induced suppression of NF-kB activity. In vivo, the 
expression of Sp transcription factors Sp1, Sp3 and Sp4 and Sp-regulated genes survivin 
and VEGF were significantly decreased in Pg-treated animals and this was accompanied 
by a decreased expression of miR-27a. Our previous studies with betulinic acid showed 
a significant decrease in tumor size in a model of ER-negative breast cancer in athymic 
female nude mice xenografted with MDA-MB-231 cells, where also miR-27a-ZBTB10-
Sp was involved in the underlying mechanism [139]. This further confirms the role of 
miR-27a in the cytotoxicity of Pg in this study. 
Several studies show that NF-kB –activity, at least in part, is mediated through 
AKT, a kinase that in part is regulated  through PI3K a key regulator in cell survival and 
cell function [69, 106].  Inositol 5'- phosphatase (SHIP-1) a 145-kDa protein that 
contains a Src homology 2 domain is a regulator of phosphatidylinositol 3,4,5- 
trisphosphate (PI3K) [197-199]. SHIP-1 has been identified as a tumor suppressor in 
hematopoietic cancer [200-202] but the role of SHIP-1 in solid tumors has not been 
thoroughly investigated. In this study, Pg induced activation of NF-kB by inhibiting the 
phosphorylation of p65 as well as the phosphorylation of PI3K/p85, and AKT (Ser473). 
These findings are inconsistent with previous studies where it was demonstrated that 
pomegranate extracts decreased inflammation and repressed lung tumors in mice and 
also decreased PI3K-dependent phosphorylation of AKT phosphorylation and activation 
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of NF-κB were decreased [69, 106]. Based on these reports one of the objectives of this 
research was to determine whether the inhibition of NF-kB activity by Pg, was due, in 
part by SHIP-1-PIP3-AKT-NF-kB interactions. Pg extract increased expression of SHIP-
1 protein which was accompanied by down-regulation of miRNA 155). SHIP-1 is 
regulated by miR-155 via a target-binding site in the 3’ UTR region of the SHIP-1 
mRNA [191]. Previously, the polyphenolics resveratrol and quercetin decreased miR155 
levels in THP-1 monocytic cells (36). In this study Ant-miR-155 and Pg decreased miR-
155 and  increased SHIP-1 mRNA [185, 191] and  si-SHIP-1 increased the 
phosphorylation of AKT, while Pg (and also as-miR-155) partially reversed this effect. 
Ant-miR-155 also decreased the activity of NF-kB in a concentration-dependent manner 
in cells transfected with pNF-κB-luc and in vivo, Pg extract decreased the expression of 
miR155. Pg increased both, SHIP-1 mRNA and protein expression where the 
phosphorylation of AKT and PI3K protein expression compared to tumors from control 
animals. Based on result of our mimic and inhibitor studies and on previous reports, we 
conclude both miR-27a and miR-155 are targets of Pg and their downregulation plays a 
significant role in the anti-inflammatory and cytotoxic efficacy of pomegranate extract 
and possibly other botanicals (Figure 35). 
Conclusion 
In summary, pomegranate extract exhibited cytotoxic and anti-inflammatory 
activities in breast cancer cells in vitro and in vivo. In addition there is evidence that 
these activities are significantly mediated in part through the effects of pomegranate 
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extract in miR-27a-ZBTB10-Sp and miR-155-SHIP1- PIP3-AKT-NF-kB interactions 
(Figure 36). 
 
 
 
Figure 35 Schematic representation showing molecular mechanisms involved in breast cancer treated with 
Pg polyphenols Pg targeted both miR-27a and miR-155 by modulating both miR-27a-ZBTB10-Sp and 
miR-155-SHIP1- PIP3-AKT-NF-kB axes 
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Figure 36 The effects of Pg extract in miR-27a-ZBTB10-Sp and miR-155-SHIP1- PIP3-AKT-NF-kB 
interaction
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CHAPTER III 
GALLOTANNINS AND GALLIC ACID CONSTITUENTS OF MANGO JUICE 
(MANGIFERA INDICA L) SUPPRESSED BREAST CANCER TUMOR GROWTH 
BY TARGETING PHOSPHATIDYLINOSITOL3-KINASE (PI3K)-AKT-NF-KB 
PATHWAY AND ASSOCIATED MICRORNAS 
                                                              
  
Summary 
The cytotoxic and anti-inflammatory properties of polyphenolics have been 
demonstrated in numerous types of cancer. The objective of this research was to 
understand the post-transcriptional targets involved in anti-inflammatory and pro-
apoptotic pathways in the breast cancer cells BT474 treated with a polyphenolic extract 
(2.5-40µg/ml) rich in gallotannins and gallic acid from mango fruit in vitro and in 
athymic nude mice bearing BT474 cells as xenografts.  
Results show that cell proliferation as well as tumor size and weight in vivo 
was decreased by polyphenolics 60% and 70% in vitro and vivo, respectively. NF-kB 
protein and mRNA expression as well as activation were decreased in a dose-dependent 
manner (0.6 fold). 
The extract also inhibited PI3K-dependent phosphorylation of AKT and 
expression and this was accompanied by down-regulation of miRNA 126 of BT474 
(2.25 fold) and in vivo. NFκB-dependent genes involved in apoptosis-inhibition, 
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metastasis and angiogenesis, such as survivin, VCAM-1, and VEGF were also 
decreased, in vitro and in vivo.  
A microRNA-array was also used to investigate whether microRNAs with 
target regions within genes were affected by the polyphenolic extract and results show 
that miR-126 Let7a and Let7b significantly increased with our extract. 
In summary the anti-carcinogenic and anti-inflammatory activity of mango 
polyphenolics in breast cancer cells were at least in part due to targeting miR-126 -
Phosphatidylinositol 3-kinase (PI3K)-AKT -NF-kB  which plays an important role in the 
proliferative/ inflammatory phenotype exhibited in this breast cancer cell line. 
Introduction 
Breast cancer is one of the leading causes of cancer death among women 
worldwide. According to the American Cancer Society, 226,870 new cases of breast 
cancer with 39510 deaths from breast cancer were diagnosed among women in 2012. 
Epidemiological studies have suggested dietary polyphenols from fruits and vegetables 
reduced the risk of cancer and cardiovascular diseases [87, 104, 129, 203, 204]. In 
addition to available therapies, several alternative natural dietary polyphenols have been 
proposed as chemopreventive and chemotherapeutic agents for breast cancer [151, 205, 
206].  
Mango (Mangifera indica L.) is a tropical fruit, rich in bioactive compounds 
consumed worldwide. Polyphenols are present in mango pulp, peel, and seed. Mango 
polyphenols have shown potential health benefits and exert antioxidant, anti-
inflammatory and antitumorogenic effects. Additionally mango polyphenols inhibit cell 
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proliferation in several cancer cell lines such as colon, lung, prostate and breast, cancer 
cells [86, 87, 111, 151]. Chemical analysis showed that the most predominant and 
relevant therapeutic compounds present in mango pulp extract are gallotannins, gallic 
acid, galloyl glycosides and flavonoids such as quercetin and kaempferol glycosides. 
Mango extract also contains mangiferin and a complex mixture of other antioxidant 
polyphenols [71, 72]. Literature have shown antitumorogenic activity of mango 
polyphenols against the estrogen positive and negative breast cancer cell lines MCF-7 
and MDA-MB-231 [205, 207]. Another important mango polyphenol, mangiferin, have 
shown chemopreventive and chemotherapeutic action against benzo(a)pyrene induced 
lung cancer in swiss albino mice [154]. Similarly, mango polyphenols were known to 
suppress prostate cancer in mice and in human prostate LNCaP cell line through 
apoptosis [111]. 
Previous studies have shown the anti-proliferative and anti-inflammatory 
properties of mango extract [86, 87, 111, 151]. The potential role of polyphenols present 
in mango showed antioxidant and anti-inflammatory properties by modulating several 
cell signaling pathways in the cancer model.  The transcription factor NF-κB plays a 
central role between inflammation and cancer [103]. NF-κB regulated genes are 
involved in cell proliferation, inflammation, angiogenesis and metastasis in cancer 
development [96, 138, 152, 153]. In cancer, NF-κB remains activated and highly 
expressed [96, 138]. Several literatures showed that polyphenols were known to target 
the NF-κB pathway [69, 97, 99, 138, 208]. Similarly polyphenols have been shown to 
reduce inflammation and inhibit lung-tumor growth in mice by suppressing PI3K-
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dependent phosphorylation of AKT and reduce the activation of NF-κB in vivo [69, 
106]. In our previous study we demonstrated the cytotoxic effect of pomegranate 
polyphenols which suppressesd the phosphorylation of NF-κB expression [50].  
In this study, our preliminary data showed that gallic acid, mono-gallyl 
glucoside, tetra -gallyl glucoside, penta- gallyl glucoside, OH-benzoic acid hexoside and 
unresolved gallotannins rich mango polyphenols (Mg) suppressed cell proliferation in 
breast cancer BT474 cell line and tumor growth in athymic BALB/c nude mice with 
BT474 xenografts. The overall antitumorgenic potential of Mg may at least in part be 
based on anti-inflammatory and cytotoxic properties that inhibit cell proliferation and 
modulate molecular pathways in breast cancer cells. Mg suppressed phosphorylation of 
NF-κB which is accompanied by the downregulation of PI3K-dependent 
phosphorylation of AKT.  In addition, Mg also reduced the expression of mammalian 
target of rapamycin (mTOR) and its downstream transcription factor hypoxia-inducible 
factors (HIF-1α). Our preliminary microRNA profile screening indicated Mg targets 
several microRNA which are important in cancer cell proliferation.  
Hence, the objective of this study was to investigate the anti-inflammatory and 
cytotoxic effects of mango polyphenols through PI3K-AKT- NF-κB pathways and 
associated microRNA’s. 
Materials and methods 
Botanical extracts 
Mango, variety Keitt, was sourced from Mexico, and were allowed to ripen and 
subsequently processed by removing peel and seed. Pulp was diced, vacuum sealed and 
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stored at -20° C until used.  Mango pulp was extracted following the methods of [209]. 
Briefly, mango pulp was extracted with a mixture of ethanol, methanol, acetone (1:1:1) 
three times the weight of the mango at ambient temperature for 1 h. Solids were 
removed by filtration and extracted twice more following the same procedures 
described. The filtered extract was evaporated and further concentrated on a 20 g C18 
cartridge (Waters Corp. Milford, MA). The unbound fraction from C18 was partitioned 
into ethyl acetate twice to capture polar compounds that were not retained by C18.  Ethyl 
acetate fraction and C18 elutant were combined and the solvent removed under reduced 
pressure at 45°C.  The dried extract was stored at -80°C prior to weighing and dissolved 
in dimethyl sulfoxide (DMSO) for cell culture and analytical procedures.   
HPLC-PDA analysis  
Separations were made in an Acclaim™ C18 column (Bannockburn, IL), (250 x 
4.6 mm, 5 µm) at room temperature. The mobile phase consisted of 0.1% formic acid in 
water (Phase A) and 0.1% water (Phase B). A gradient program at 0.4 mL/min initially 
ran Phase B at 0%, for 3 minutes,  21%  Phase B in 20 min, from 21 to 35% Phase B in  
30 min, and 35 to 49% Phase B in 50 min, 49% to 70% Phase B in 70 minutes before 
returning to initial conditions. Detection was at 280 and 360 nm for benzoic and 
cinnamic acids/flavonoids, respectively. Compounds were tentatively identified based on 
mass spectometry analysis. This was performed on a Thermo Finnigan LCQ Deca XP 
Max ion trap mass spectrometer with an electrospray ionization probe in negative ion 
mode under the following conditions sheath gas (N2), 40 units/min; auxiliary gas (N2), 5 
  
85 
 
units/min; spray voltage, 4.5 kV; capillary temperature, 300°C; capillary voltage, 7.0 V; 
tube lens offset, 40.0 V, the source current at 80.0 µA.  
Cell culture  
Human mammary carcinoma cell lines were purchased from ATCC and 
maintained the cells according to the supplier guidelines (American Type Tissue 
Collection (ATCC, Manassas, VA).  
Cell proliferation 
The cell proliferation was measured using an electronic particle counter at 48 h 
(Z1™ Series, Beckman Coulter, Inc, Fullerton, CA), on BT474 cells after a 48h 
treatment with Mg extract as previously described, [50] and are presented as net growth. 
Reagents 
Primers for VEGF, PI3K, AKT and HIF-1α were purchased from Integrated 
DNA Technologies (San Diego, CA). Scrambled miRNA was obtained from 
Dharmacon, Inc. (Lafayette, CO). mirVana TM extraction kit, reverse transcription (RT) 
and real-time PCR amplification kits were purchased from Applied Biosciences (Foster 
City, CA). We have purchased antibodies against, poly-(ADP-ribose)-polymerase 
(PARP), NF-κB (p65), phosphorylated NF-κB (p65), PI3K, mTOR and HIF-1α from 
Cell Signaling Technology (Beverly, MA). Rest antibodies were purchased from Santa 
Cruz Biotechnology Inc. (Santa Cruz, CA). Western blotting chemiluminescence reagent 
was purchased from Perkin-Elmer Life Sciences (Waltham, MA).   
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Real-time PCR analysis of mRNA  
As described in previous literature BT474 cells were seeded in 6 well plate for 
24 h to allow cell attachment [50]. Cells were treated with Mg extract and after 24 h 
mRNA was extracted for gene expression analysis as previously described [50]. 
According to the manufacturer’s recommended protocol total RNA was isolated by 
using the RNeasy Mini kit (Qiagen, Valencia, CA) for mRNA analysis and for micro-
RNA analysis the mirVanaTM miRNA isolation kit (Applied Biosystems, Foster City, 
CA). RNA purity was assessed using spectrophotometry (260/280 > 1.7). Total RNA 
concentration was determined by the NanoDrop® ND-1000 Spectrophotometer 
(NanoDrop Technologies, Wilmington, DE). According to the manufacturer‟s protocol 
cDNA was synthesized from isolated RNA using a Reverse Transcription Kit 
(Invitrogen Corp., Grand Island, NY). SYBR Green PCR Master Mix from Applied 
Biosystems (Foster City, CA) were used to carry out qRT-PCR on an ABI Prism 7900 
Sequence Detection System (Applied Biosystems Inc, Foster City, CA). as previously 
described [50] on an ABI Prism 7900 Sequence Detection System (Applied Biosystems 
Inc, Foster City, CA). The pairs of forward and reverse primers were purchased from 
Integrated DNA Technologies, Inc. (Coralville, IA).  All primers were designed using 
Primer Express software (Applied Biosystems, Foster City, CA). Each primer 
homology-search was performed by an NCBI BLAST search to ensure that it was 
specific for the target mRNA transcript., Inc. (San Diego, CA). Product specificity was 
determined by dissociation curve analysis. We followed the protocol as described 
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previously [50, 140]. The primer-sequences for VEGF were F:5’- AAG GAG GAG 
GGC AGA ATC AT-3’, and  R:5’- ATC TGC ATG GTG ATG TTG GA-3’.   
MicroRNA profiles screening 
Total RNA was isolated from the tumor samples using the mirVana™ miRNA 
Isolation Kit. cDNA synthesis and real-time qPCR was performed as described in the 
manual of Megaplex™ Pools A without pre-amplification (Applied Biosystems, Foster 
City, CA, USA). In brief, Equal amount (500ng) of total RNAs (n=3/group) was reverse 
transcribed to cDNA using Megaplex RT Primers and TaqMan MicroRNA Reverse 
Transcription kit. The megaplex product was loaded onto the TaqMan Human 
MicroRNA Array (Applied Biosystems, Foster City, CA, USA) to quantify individual 
miRNAs. The array was performed using a 7900HT system with an SDS software v.2.3. 
Only miRNA showing >2-fold increases or <0.5-fold decreases were shown in the 
results section.  
Western blotting  
BT474 cells (4 × 105) were seeded in 6-well plates and incubated for 24 h. 
They were also treated with Pg extract (0-10µg/mL) for 24 h. Cells were harvested and 
prepared for western blotting using a Bio-Rad protein kit. (Bio-Rad, Hercules, CA)  as 
previously performed [50, 140]. 60µg of cell lysate was resolved by electrophoresis in 
10% sodium dodecyl sulfate (SDS) polyacrylamide gel (100 v, 1.5 h) in a running gel 
buffer (containing. 25 mM Tris, pH 8.3, 162 mM glycine, and 0.1% SDS). The samples 
were transferred to nitrocellulose membrane for 1h at 350 mA. The membrane blocked 
for 1h in 5% skimmed milk dissolved in a mixture of T-PBS with 0.1% tween. The 
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membranes were incubated overnight in a mixture of 3% BSA (fetal bovine serum) in T-
PBS with 0.1% tween and primary antibody dilutions based on manufacturer protocol. 
Next day the membrane was incubated in secondary antibody for 1 h at room 
temperature.  Proteins were visualized with a Kodak Molecular Imaging System 
(Carestream Health, Rochester, NY). β-actin was used as an internal control to ensure 
equal amount of protein was loaded per well.  
Multiplex bead assay 
 By using the multiplex kits (#48-611, #48-612, Millipore) according to the 
manufacturer’s protocol the protein extract (20ug) from each tumor tissue from mice 
bearing BT474 xenografts was used to determine the relative abundance of the 
phosphorylation status and total protein in the AKT/mTOR signaling (kit contained 
AKT, GSK3β, GSK3α, IGF1R, IR, IRS1, mTOR, p70 S6 kinase, PTEN, RPS6, and 
TSC2). Multiplex analysis was performed by the Luminex L200 instrument (Luminex, 
Austin, TX), and data was analyzed by Luminex xPONENT software [210]. 
Xenograft study 
From Harlan laboratory (Houston, TX) female athymic BALB/c nude mice 
(age 3- 4 weeks) were purchased and implanted with  BT474 cells (2X106 cells) in 
matrigel (BD Bioscience San Jose, CA) s.c into the flank [50].   After approval by the 
Institutional Animal Care and Use Committee at Texas A&M University (College 
Station, TX) mice were utilized after a 10 day equilibrium period. Mice were treated 
with either 100 µl vehicle 0.8mg Gallic acid equivalent (GAE)/kg/day of Mg extract/d or 
1% DMSO in corn oil by oral gavage for 35 days. Final body and tumor weights were 
  
89 
 
determined. Tissues were flash-frozen in liquid nitrogen and stored at -80˚C for mRNA 
and protein analysis. 4-AM-thick paraffin-embedded tumor sections were cut and stained 
with Hematoxylin and Eosin (H&E) for bright field microscopy. 
Statistical analysis 
Quantitative data represent mean values with the respective standard deviation 
(SD) or standard error of the mean (SE) corresponding to replicate. Data were analyzed 
by one-way analysis of variance (ANOVA) using SAS version 9.3 (SAS Institute Inc., 
Cary, NC).Tukey’s Post Hoc multiple comparisons was used (p<0.05) to develop 
significant statistical difference.  
Results 
Polyphenolic composition of pomegranate extract determined by HPLC-MS  
The polyphenolic profile of mango was previously shown as being rich in 
gallotannins, gallic acid, galloyl glycosides and flavonoids such as quercetin and 
kaempferol glycosides. Mango has also been reported to contain a mangiferin and 
complex mixture of other antioxidant polyphenols [71, 72]. In this study, HPLC-MS 
analysis (Figure 37 ) indicated the presence of gallic acid, mono-galloyl glucoside, tetra 
–galloyl glucoside, Penta- Galleo glucoside , OH-benzoic acid hexoside and unresolved 
gallotannins as the major polyphenols present in the mango pulp extract.  
Anti-proliferative activities of mango extract  
Mango extracts exerted cytotoxic activity in human BT474 breast cancer cell-
lines (Figure 38A) After treatment with Mg extract (2.5-25 µg/ml), there was a 
concentration-dependent decrease in cell viability after 48 h. Mg-induced cytotoxicity 
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was accompanied by activation of the cleaved product of the substrate Poly (ADP-
ribose)-polymerase1 (PARP) [186] and suppressed the expression of survivin, important 
for cell proliferation (Figure 38B) 
 
 
 
 
 
  
 
Figure 37 Representative chromatogram of polyphenolic compounds in an extract of mango juice 
concentrate gallic acid, mono-galloyl glucoside, tetra –galloyl glucoside, penta- gallyl glucoside , a OH-
benzoic acid hexoside and unresolved gallotannins as the major polyphenols present in the mango pulp 
extract 
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Figure 38 Mango extract (Mg) inhibits proliferation and induces apoptosis in cancer cells (A) cells were 
seeded and treated with DMSO (vehicle control) or different concentrations of Mg extract (2.5-20 µg/ml 
treatment) for 48 h as described in the materials and methods section. (B) western blot analysis of 
apoptosis-associated proteins (cleaved PARP) and cell survival protein (Survivin). BT474 cells were 
treated with DMSO (control vehicle) or different concentrations of Mg extract 2.5-10 µg/ml for 24 h, and 
whole-cell lysates were analyzed by western blot analysis as described in the material and methods 
section.  All experiments were performed at least three times and the results were expressed as mean ± SE; 
* indicates significant changes at p<0.05. 
 
 
 
Modulation of PI3K /AKT /mTOR pathway 
The PI3K/AKT/ mTOR are well known for their role in carcinogenesis 
processes in  several types of cancer such as colon, lung and breast cancer [211, 212]. 
PI3K/AKT controls cell proliferation and initiates cell survival pathways through 
phosphorylation of several downstream targets such as NF-κB and mammalian target of 
rapamycin (mTOR) [213-215]. Our previous study showed the cytotoxic effects of 
polyphenols from pomegranate in part mediated through PI3K/AKT in BT474 breast 
cancer cells in vitro and vivo [50]. In this study, mango polyphenols decreased HIF-1α, 
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pPI3K, pAKT and VEGF mRNA level (Figure 39 A) pPI3K, pAKT, AKT, VEGF and 
VEGFR protein levels (Figure 39B) . 
Effects of Mg on NF-κB  
In our previous study anti-inflammatory properties of pomegranate polyphenol 
were shown by inhibiting the expression of constitutive and phosphorylation of NF-κB 
p65 in breast cancer cells BT474 [50]. Literature showed other dietary polyphenols such 
as curcumin, suppressed NF-κB  expression in pancreatic tumor growth and cancer cell 
lines [138]. Similarly, in this study we have investigated cytotoxic and anti-
inflammatory properties of mango polyphenols. Mg suppressed the constitutive 
expression and phosphorylation of NF-κB p65 in BT474 cells (Figure 39C).  
 
 
 
Figure 39 Mango extract (Mg) inhibits phosphorylation of AKT/PI3K/mTOR pathways and inhibits 
angiogenesis marker vascular endothelial growth factor (VEGF) and its receptor (VEGFR) in cancer cells 
(A) effects of Mg on HIF-α, PI3K, AKT and VEGF mRNA levels and (B), pP13K, pAKT AKT,VEGF 
and VEGFR protein expression (C) NF-κB (p65) and pNF-κB (p65) protein expression in BT474 cells. 
Cells were treated with solvent DMSO (control) or different concentration of Mg (2.5-10 µg/ml) for 24 h. 
All experiments were performed as described in the material and method section at least in triplicates and 
result were expressed as mean ± SE.* indicates significant changes from the control at p<0.05 
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Xenograft study in athymic female nude mice  
Our previous study demonstrated cytotoxic activities of Pg in athymic female 
nude mice with BT474 cells as xenografts. Similarly in the present study, treatment with 
Mg (0.8mg GAE/kg/day/) significantly suppressed tumor volume (Figure 40A) and 
cleaved poly (ADP-ribose)-polymerase1 (PARP) upregulated (Figure 40B) Moreover, 
Mg decreased the expression of pPI3K pAKT mTOR protein level (Figure 40B) and 
significantly suppressed expression of HIF-1α downstream of mTOR pathway (Figure 
40B). NFkB p65 protein levels were also inhibited in tumors from mice treated with Mg 
compared to the control tumors (Figure 40B). Similar results of pAKT and pmTOR 
protein level were observed through Luminex assay. VEGF protein expression was 
reduced in Mg treated group (.Figure 41A). Tissues collected from mice tumor were 
flash-frozen in liquid nitrogen and stored at -80˚C for mRNA and protein analysis. 4-
AM-thick paraffin-embedded tumor sections were cut for immunohistochemistry and 
stained with VEGF primary antibody and images were taken for bright field microscopy 
(Figure 41B). 
In addition our preliminary microRNA profile screening indicated that Mg 
targets several microRNA that are important in cancer cell proliferation. Tumor 
suppressor microRNA miR494, miR 31, let7b, let7a, miR708 and miR126 are 
upregulated whereas oncogenic miR221 expression was downregulated with the 
treatment of Mg (Table 4). 
 
  
94 
 
 
Figure 40 In vivo studies athymic nude mice A) tumor Volume (B) effects of Mg on apoptosis-associated 
proteins (cleaved PARP), pNF-κB (p65), pAKT, pPI3K, mTOR and HIF-α, protein expression through 
western blotting (C), pAKT and pmTOR protein expression through luminex assay. Athymic nude mice 
(10 per group) bearing BT474 cells as xenografts were treated with corn oil (control) or Mg extract in corn 
oil (0.8 mg Gallic Acid Equivalent (GAE)/kg/day) every day as described in the materials and methods. 
All experiments were performed as described in the material and method section at least in triplicates and 
result were expressed as mean ± SE.* indicates significant changes from the control at p<0.05. 
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Figure 41 Effects of Mg on VEGF protein expression in expression in mice with BT474 xenografts (A) 
VEGF protein expression through western blotting in control and Mg treated group (B) immuno-histology 
staining with VEGF in control and Mg treated group. All experiments were performed as described in the 
material and method section at least in triplicates and result were expressed as mean ± SE.* indicates 
significant changes from the control at p<0.05
 
 
Table 4 The relative levels of miRNA gene expression from the mango group to control group were 
compared in mice with BT474 xenografts. MicroArray data 
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Discussion 
Mango is a rich source of nutritive compounds, such as polyphenols, present in 
pulp, peel, and seed. The most predominant therapeutic compounds present in mango 
extract are gallotannins, gallic acid, galloyl glycosides and flavonoids, such as quercetin 
and kaempferol glycosides. Gallotannins, one of the main polyphenolics identified in 
mango, has been shown to modulate the pro-apoptotic and cell cycle related proteins in 
colon cancer  cells [216].  
In theory, these polyphenolic compounds reduce risk of cancer, cardiovascular 
and several other chronic diseases, yet little research has been conducted to investigate 
the efficacy of whole fruits. Compared to whole fruit polyphenols, individual isolated 
compounds appear to be less important, as they remain at higher levels than their actual 
appearance in plasma after consuming whole fruits [86, 87, 111].  
Previous studies have shown potential health benefit of mango polyphenols, 
which exerts antioxidant, anti-inflammatory, anti-carcinogenic and anti-proliferative 
activities.  It induce apoptosis in cancer cell lines including breast, prostate and colon 
cancer involving caspase-2, -3, and -9 [86, 87, 111, 151].  
We have recently reported the cytotoxic effect of polyphenol extract from 
whole fruit pomegranate in breast cancer cells and nude mice containing breast cancer 
cell xenografts by targeting AKT/ PI3K/p85 pathway [50]. In the present study, we have 
demonstrated the anti-carcinogenic and anti-proliferative activities of a mango extract in 
breast cancer cells and in an animal model. Our preliminary data indicates the presence 
of gallic acid, mono-galloyl glucoside, tetra –galloyl glucoside, penta- gallyl glucoside, 
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OH-benzoic acid hexoside and unresolved gallotannins as the major polyphenols present 
in the mango pulp extract. The result of the present study showed that gallic acid and 
gallotannin rich mango pulp extract (Mg) inhibited cell proliferation of breast cancer cell 
line BT474 by activating cleaved product of the substrate Poly (ADP-ribose)-
polymerase1 (PARP) and inhibited expression of survivin. Mg also suppressed tumor 
growth in athymic BALB/c nude mice with BT474 xenografts. 
Several literature studies have indicated that NF-kB –activity, at least in part, is 
mediated through AKT, a kinase, that in part is modulated  by PI3K, a key regulator in 
cell survival and cell function [69, 106]. In this study, mango polyphenols (Mg) 
suppressed phosphorylation of NF-κB (p65) which is accompanied by downregulation of 
PI3K-dependent phosphorylation of AKT (Ser473). Thus Mg was shown to modulate 
the expression of AKT/ PI3K/p85 pathway (Figure 42). In addition, Mg also reduced the 
expression of mammalian target of rapamycin (mTOR) and its downstream transcription 
factor hypoxia-inducible factors (HIF-1α). The PI3K/AKT/ mTOR are well known for 
the carcinogenesis progression in  several types of cancer such as colon, lung and breast 
cancer [211, 212]. PI3K/AKT controls cell proliferation and initiates cell survival 
pathways through phosphorylation of several downstream targets such as NF-κB and 
mammalian target of rapamycin (mTOR) [213-215]. Mg also reduced expression of 
angiogenesis marker such as vascular endothelial growth factor (VEGF) and its receptor 
VEGFR. Similar results were observed in athymic BALB/c nude mice with BT474 
xenografts. 
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Our preliminary microRNA profile screening indicated that Mg targets several 
microRNA that are important in cancer cell proliferation. Tumor suppressor microRNA 
miR494, miR 31, let7b, let7a, miR708 and miR126 are upregulated, whereas the 
expression of oncogenic miR221 was downregulated with the treatment of Mg. miR494 
suppressed cell proliferation, miR 31 inhibited breast cancer metastasis and miRNA221 
induce cell proliferation and angiogenesis. Let7b and let7a reduced tumor growth, 
miR708 induced cell proliferation and miR126 controlled cell angiogenesis. Thus 
preliminary data of miRNA screening indicate that Mg modulated the expression of 
different miRNA involved in carcinogenesis progression.  
Conclusion  
In summary, Mg exhibited antioxidant, anti-inflammatory, anti-carcinogenic 
and anti-proliferative activities in breast cancer cells in vitro and in vivo. In addition Mg 
inhibited cell proliferation of breast cancer cell line BT474 and suppressed tumor growth 
in athymic BALB/c nude mice with BT474 xenografts. Mg modulates the expression of 
miRNA regulated cell proliferation.  
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Figure 42 Schematic representation showing mango polyphenols targeted miR126  which modulated 
PI3K/AKT pathway and also NF-κB and VEGF expression
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CHAPTER IV 
POMEGRANATE EXTRACT CONTAINING ELLAGITANNINS AND 
ANTHOCYANINS SUPPRESSED AZOXYMETHANE-INDUCED COLORECTAL 
ABERRANT CRYPT FOCI (ACF) AND INFLAMMATION: POSSIBLE ROLE OF 
MIR126-VCAM-1 AND MIR126-PI3K/AKT-MTOR* 
 
 
Summary  
The antitumorigenic activities of polyphenols such as ellagitannins and 
anthocyanins in pomegranate (Punica granatum L.) have been previously studied where 
cytotoxic, anti-inflammatory and antioxidant effects were evident in various cancer 
models. The objective of this study was to investigate the role of miR-126/VCAM-1 and 
miR-126/PI3K/AKT/mTOR in pomegranate-mediated anti-inflammatory and anti-
carcinogenic effects in vivo and in vitro. Sprague Dawley rats (n=10/group) received 
pomegranate juice (2504.74mg gallic acid equivalents/L) or a polyphenol-free control 
beverage ad libitum for 10 weeks and were injected with azoxymethane (AOM) 
subcutaneously (15 mg/kg) at weeks 2 and 3. Consumption of pomegranate juice 
suppressed the number of aberrant crypt foci (ACF) and dysplastic aberrant crypt foci by 
29% and 53.5% (P=0.05 and 0.04) respectively, and significantly lowered proliferation 
* Reprinted with permission from “Pomegranate Polyphenolics Suppressed Azoxymethane-Induced 
Colorectal Aberrant Crypt Foci (ACF) and Inflammation: Possible role of miR126-VCAM-1 and 
miR126-PI3K/AKT-mTOR”, by Banerjee N, Hyemee K, Talcott S and Mertens –Talcott SU, 2013, 
Carcinogenesis. 34, 2814-2822, Copyright 2013 by  Oxford 
________________________
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of mucosa cells. Pomegranate juice significantly downregulated pro-inflammatory 
enzymes iNOS and COX-2 mRNA and protein expression. In addition, it suppressed 
NF-kB and VCAM-1 mRNA and protein expression in AOM treated rats. Pomegranate 
also inhibited phosphorylation of PI3K/AKT and mTOR expression, and increased the 
expression of miR-126. The specific target and functions of miR-126 were investigated 
in HT-29 colon cancer cell lines. In vitro, the involvement of miR-126 was confirmed 
using the antagomir for miR-126, where pomegranate reversed the effects of the 
antagomir on the expression of miR-126, VCAM-1 and PI3K p85b. In summary, 
therapeutic potentials of pomegranate in colon tumorigenesis were due to in part to 
targeting miR-126-regulated pathways, which contributes in the underlying anti-
inflammatory mechanisms.   
Introduction  
Colorectal cancer is the third leading cause of death in the US [3]. According to 
epidemiological and intervention studies, colon carcinogenesis is significantly 
influenced by dietary, genetic, and environmental factors. These factors may cause 
disruption of normal cell growth, uncontrolled proliferation and differentiation 
associated with inflammation and oxidative stress. Owing to the low survival rate of 
colon cancer, it is crucial to investigate nutritional prevention approaches and their 
underlying mechanisms of action [93, 215].  
Epidemiological, preclinical and clinical studies suggest that a diet rich in 
natural polyphenolics may protect against colonic inflammation and colon cancer [44-
46]. Clinical and preclinical studies have reported that polyphenolics from pomegranate 
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exert anti-carcinogenic, anti-inflammatory and antioxidant activities [47-50]. 
Polyphenols extracted from pomegranate peels and seed, have shown to induce 
cytotoxicity in several cancer cell lines such as lung, prostate and breast and also in 
chemically-induced colon cancer in animal studies [47, 49, 108, 109, 119, 165, 217]. 
Predominant polyphenolics in pomegranate include ellagic acid, ellagitannins, 
punicalagin, flavonoids, and 3-glucosides/3,5-diglucosides of the anthocyanins 
delphinidin, cyanidin, and pelargonidin [50, 70] and these exhibit antioxidant, anti-
inflammatory, and anti-carcinogenic properties in vitro and vivo [113, 218, 219]. 
Previous studies have demonstrated the downregulation of a common colon 
cancer marker vascular cell adhesion molecule 1 (VCAM-1) [220, 221] by polyphenols 
[222]. In addition, pomegranate polyphenols also modulates the expression of 
phosphatidylinositol-3- kinase (PI3K)/AKT pathways. In the human lung carcinoma 
cells (A549) and lung tumors in mice, where inflammation was induced by the induction 
of NF-κB and PI3K/AKT signaling pathway, pomegranate polyphenols down regulated 
inflammation by suppressing PI3K and AKT phosphorylation and decreased the 
activation of NF-κB [69, 106]. Insulin growth factor (IGF) influences the regulation of 
the phosphorylation of PI3K/AKT which is crucial in the pathogenesis of colon cancer. 
PI3K/AKT pathway influences cell survival through phosphorylation of downstream 
targets such as NF-kB, and mammalian target of rapamycin (mTOR). NF-kB regulates 
inflammatory markers including inducible nitric oxide synthase (iNOS) and 
cyclooxygenase-2 (COX-2) [223].  
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The anti-inflammatory miR-126 has target regions in the promotor regions of 
VCAM-1 and PI3K p85β subunit, and low expression of miR-126 has been associated 
with colon cancer [211, 224]. It also was previously shown that pomegranate increased 
the expression of miR-126 and that is involved down-regulating VCAM-1 and PI3K 
[211, 225].  
In our preliminary studies in HT-29 colon cancer cells, Pg induced apoptosis 
and increased the expression of miR-126, suppressed VCAM-1, NFkB, iNOS, COX-2 
and decreased the phosphorylation of AKT. Based on these preliminary in vitro findings, 
the objective of this study was to investigate the efficacy and underlying mechanisms of 
Pg in the prevention of AOM-induced aberrant foci in a rat model. The working 
hypothesis was that miR126-VCAM-1 and miR126-PI3K/AKT-mTOR are significantly 
involved in the anti-inflammatory, cytotoxic and cancer-preventive activities of Pg in 
AOM-treated rats and also in vitro in HT-29 colon cancer cell. 
Materials and methods 
Experimental juice and extract  
Rats were divided into two groups Control juice or Pomegranate juice. 
Pomegranate juice was obtained from the Stiebs (Kirkland, WA). For calorie adjustment, 
15.7g sugar and 0.05g citric acid were added in 100ml of Control juice. Total phenolic 
content in the Pomegranate juice was meassured spectrophotometrically by the Folin-
Ciocalteu assay against an external standard of gallic acid and expressed as gallic acid 
equivalents. The extract was prepared following the procedure described in our previous 
literature [50]. 
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Reagents 
Standards for HPLC-MS analysis were obtained from Sigma-Aldrich (St Louis, 
MI) and Chromadex (Irvine, CA). Antibodies against NF-κB (p65), phosphorylated NF-
κB (p65), COX-2, iNOS, IGF, pmTOR were purchased from Cell Signaling Technology 
(Beverly, MA). All other antibodies were purchased from Santa Cruz Biotechnology Inc. 
(Santa Cruz, CA). Western lighting chemiluminescence reagent was purchased from 
Perkin-Elmer Life Sciences (Waltham, MA).  All primers were purchased from 
Integrated DNA Technologies (San Diego, CA). mirVana TM extraction kit, reverse 
transcription (RT) and real-time PCR amplification kits were purchased from Applied 
Biosciences (Foster City, CA). Antagomers of miR-126 (inhibitor) as well as scrambled 
miRNA were from Dharmacon, Inc. (Lafayette, CO) [50].  
Polyphenolic composition of pomegranate juice determined by HPLC-MS  
According to our previous study, pomegranate polyphenolics predominantly 
include ellagic acid, ellagitannins, and anthocyanins [50]. The chromatographic profiles 
showed flavonoids with peak absorption at 360nm (Fig. 1A) and ellagitannins with peak 
absorption at 280nm (Fig. 1B).  
Cell culture 
Human colon carcinoma cell lines HT-29, were obtained from American Type 
Tissue Collection (ATCC) and maintained according to the supplier guidelines  (ATCC, 
Manassas, VA).  
  
105 
 
Cell proliferation 
The cell proliferation was assessed with an electronic cell counter at 48 h 
(Z2™ Series, Beckman Coulter, Inc, Fullerton, CA),  as previously described [33] and 
were showed as net growth.  
Animal treatments and tissue collection 
Twenty male Sprague-Dawley rats (3 week-old) supplied from Harlan Teklad 
(Houston, TX) were randomly distributed by weight into Control juice and Pomegranate 
juice groups. Animals were kept in suspended cages in a room controlled at a 
temperature of 23±2°C, humidity of 55±5% and 12 h light/dark cycle, and they had free 
access to regular food pellets and experimental juices. All rats were given intra-
peritoneal injection of azoxymethane (AOM; 15 mg/kg body weight; Sigma Chemical 
Co., St Louis, MO) twice, at 2 and 3 week, after starting the experimental diets. Rats 
were sacrificed 6 weeks after the second AOM injection, and colon tissues were 
collected. One centimeter sections were cut from the distal end of each rat colon, fixed in 
4% paraformaldehyde (PFA), and then embedded in paraffin. Half of the colon was fixed 
at 70% EtOH for aberrant crypt foci (ACF) determination and the other half was gently 
scraped for collecting protein and RNA [212, 226]. The animal use protocol was 
approved by the Institutional Animal Care and Use Committee at Texas A&M 
University. 
Assessment of aberrant crypt foci 
After 24 h of fixation in 70% EtOH, tissue was stained with 0.5% methylene 
blue for 1 min, and the total number of high multiplicity ACF (HMACF; foci containing 
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4 or more aberrant crypts)    was counted using a light microscope at 40x magnification 
[212, 226]. 
 Cell proliferation assay 
For Ki-67 immunohistochemistry analysis, sections were treated with primary 
antibody against Ki-67 (Dilution 1:50, BD Pharmingen, San Jose, CA) and incubated 
with biotinylated anti-mouse IgG, Vectastain ABC Elite kit (Vector Lab, Burlingame, 
CA). Ki-67-containing nuclei, indicative of proliferating cells, were visible as brown 
spots within colonic crypt columns. Twenty-five crypt columns per rat were selected for 
analysis. 
Quantitative RT-PCR 
Total RNA from the colon mucosal scraping was isolated using the mirVana™ 
miRNA Isolation Kit. HT-29 cells were seeded (3 × 105 cells onto a 6-well plate) and 
incubated for 24h. Cells were treated with Pg extract and mRNA was extracted after 24h 
[50]. Equal amount (1ug) of mRNAs was converted to cDNA using a reverse 
transcription kit (Invitrogen Corp., Grand Island, NY) [212, 226]. Real-time PCR 
reactions were performed using 2uL of cDNA using a Reverse Transcription Kit 
(Invitrogen). SYBR Green PCR master Mix (Applied Biosystems Inc., Foster City, CA) 
was used for the qPCR analyses on Applied Biosystems 7900HT Fast Real-Time PCR 
system (Applied Biosystems Inc., Foster City, CA). The sequence of primers was 
designed using Primer3Plus® (http://www.primer3plus.com/cgi-
bin/dev/primer3plus.cgi) and were obtained from Integrated DNA Technologies 
  
107 
 
(Coralville, IA). GAPDH was used as the endogenous loading control [50]. 
Western blotting 
The mucosal scrapings were homogenized in a protein buffer (500mM Tris-
HCL, 1M Sucrose, 200mM EDTA, 100mM EGTA, 0.4M NaF, 10% Triton X-100, 
10mM Sodium Orthovanadate, and Protease Inhibitor Cocktail), were centrifuged at 
15,000 g for 20 min at 4°C, and the supernatant was stored in a 80°C freezer [212, 226]. 
HT-29 cells were seeded (1 × 105 onto 6-well plates) and incubated for 24h to allow cell 
attachment. They were treated with Pg extract (5-25 µg/ml) for 24h and protein was 
extracted after 24h [50]. 60ug of protein was loaded onto 10% electrophoresis gel, 
followed by electrotransfer onto PVDF membranes. The blots were probed with the 
primary antibodies against VCAM (Santa Cruz biotechnology, Santa Cruz, CA), Cox-2 
(Cell signaling, Danvers, MA) and β-actin (Sigma, St Louise, MO) [50]. Transfection 
with Ant. of 126 
Cells seeded (1 × 105 onto 12-well plates) were incubated for 24h to allow cell 
attachment. Transfections with 20nM Ant. (inhibitors) of miR-126 were performed as 
previously described [227]. 
Statistical analysis 
Quantitative data represent mean values with standard error. Data were 
analyzed by one way ANOVA using Tukey’s post hoc test (p<0.05) using SAS version 9 
(SAS Institute Inc., Cary, NC)[50]. 
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Results 
Chemical analysis of pomegranate (Pg) juice 
The polyphenolics profile of Pg juice is representative of 100% pomegranate 
juice [228]. The chromatographic profiles show flavonoids with peak absorption at 
360nm (Figure 43a) and ellagitannins with peak absorption at 280nm (Figure 43b).  
 
 
 
Figure 43 Representative chromatogram of polyphenolic compounds in pomegranate juice and the daily 
juice consumption by rats (a) flavonoids at 360nm, tentative peak assignments (b) ellagitannins at 280nm, 
tentative peak assignments1 punicalins, 2 punicalagin A, 3 punicalagin B, 4 ellagic acid. (c) the daily juice 
consumption by rats was measured every day. Values are mean ± SE, n=20
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Table 5 Effects of pomegranate juice on final body weight, food and juice intake 
Group Final Body weight (g) Food intake (g/day) Juice intake (ml/day) 
Control 355.975 ± 30.007 10.460 ± 1.804    53.186 ± 11.31ns 
Pomegranate 326.557 ± 20.034* 16.956 ± 1.430* 57.211 ±16.75 
Each value is a mean ± SD (n=20). Values are statistically significant at *p<0.05. ns means not 
significantly different. Food intake was measured as the mean (± SD) weight (g) of food intake per 48 h 
period at 9 weeks after the second AOM injection. Juice intake was calculated as the mean (± SD) volume 
(ml) of juice consumed for whole study 
 
 
 
Pg intake, food intake and body weight of AOM treated rats           
The concentration of total soluble phenolics of Pg juice used for the animal 
study was 2504.74 mg/L GAE. The intake of Pg and control beverage was determined 
every alternative day (Figure 43c). For the initial 9 days, the intake of Pg was slightly 
but significantly lower compared to the control group by around 10% on average, likely 
because animals had to get used to the astringency of contained ellagitannins, however, 
the overall intake of liquids was not significantly different over the entire study duration. 
For the initial 48h after each AOM injection (week 2 and 3), the intake of liquids was 
significantly lower in the control group compared to the Pg-treated group, by 3ml and 
30ml, respectively, potentially due to ameliorating effects of Pg on appetite-suppressing 
effects of AOM. The intake of solid food was significantly higher in the Pg group by 6 
g/day compared to the control group. In contrast, the Pg group gained less weight 
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compared to the control group, where the final average body weight of the control group 
was 30g above the Pg group (Table 5).  
Pg juice inhibits high multiplicity ACF (HMACF > 4 aberrant crypts/focus) in AOM-
treated rats 
High multiplicity ACF (HMACF) is used as a marker in the assessment of the 
initial stage of carcinogenesis in rat colon of azoxymethane (AOM) treated animals. 
Developmento of preneoplastic lesions, especially HMACF is found in human and 
animal colon cancer models and is known to be predictive of colon carcinogenesis [212, 
226]. The number of HMACF was assessed over the entire length of the colon mucosa. 
The total number of HMACF was significantly decreased by the pomegranate treatment 
by 53.5% (Figure 44aand b) compared to the control group (p= 0.04).   
Pg juice suppresses cell proliferation  
Previous study show that pomegranate polyphenolics reduced cell proliferation 
in colon carcinogenesis [95]. Cell proliferation of mucosal tissue harvested from the 
colon of AOM-induced rats were determined by immunohistochemistry using the Ki67 
antibody as an indicator for the proliferative index (Figure 44c). The colon mucosa of 
Pg-treated rats showed a significant reduction of Ki67-positive nuclear staining 
compared to the control groups. In the control group, Ki67-positive nuclei staining in the 
colon mucosa were 34.24% of cells, and it was only 23.41% of the cells in Pg treated 
animals, which represents an 11% reduction compared to the control group (P=0. 0127) 
 (Figure 44d). 
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Figure 44 Effects of pomegranate juice on lesion formation and colonocyte proliferation (a) the number of 
HMACF image under light microscope. (b) the number of HMACF was significantly decreased by the 
pomegranate treatment by 53.5% compared to the control group (p=0.04). (c) Ki-67 
immunohistochemistry staining (d) pomegranate juice inhibited cell proliferation compared with the 
control juice group. Values are mean ± SE, n=20. *P < 0.05
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Pg juice suppresses the expression of inflammatory enzymes Cox-2, iNOS, NF-κB (p65) 
and VCAM-1 in rats treated with AOM 
In colon cancer, the overexpression of inflammatory marker plays a significant 
role. Previously, we demonstrated the anti-inflammatory activities of polyphenols from 
pomegranate against the inflammation in breast cancer [50]. In this study, the anti-
inflammatory activities of Pg juice in rats treated with AOM were investigated. 
Treatment of AOM-injected rats with Pg decreased the expression of COX-2, iNOS, and 
VCAM-1 mRNA and protein (Figure 45 a,b, c and d). Interactions between pomegranate 
polyphenolics and NF-κB signaling have been previously studied in several studies [69, 
106, 229]. In our previous study, Pg significantly reduced the expression of constitutive 
expression and phosphorylation of NF-κB p65 in breast cancer cells BT474 and MDA-
MB-231 [50] and revealed the anti-inflammatory properties of pomegranate 
polyphenolics. Similarly, we have found that Pg also suppressed the constitutive 
expression and phosphorylation of NF-κB p65 in colon cancer cells (Figure 45 c and d). 
Pg juice modulates the PI3K/AKTmTOR pathway in AOM treated rats 
The PI3K/AKT signaling pathway plays an important role in carcinogenesis for 
several types of cancer including colon cancer [211] and influences cell survival 
pathways through phosphorylation of downstream targets such as NF-κB and 
mammalian target of rapamycin (mTOR) [213-215]. Previously we have shown that the 
anti-inflammatory effects of polyphenols from pomegranate were in part mediated 
through the suppression of the PI3K/AKT pathway in breast cancer cells in vitro and 
vivo [50]. Insulin growth factor (IGF) regulates the phosphorylation of PI3K/AKT and 
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pmTOR. In this study, pomegranate juice decreased in the expression of insulin growth 
factor (IGF) and pPI3K accompanied by decreased expression of pAKT and pmTOR 
mRNA and protein level (Figure 45e and f ). 
Pg juice increases the expression of miR-126 in AOM-treated rats  
Small non-coding microRNAs (miRNAs) are known to influence several 
biological processes such as cell development, differentiation and maintenance, and also 
to controll the process of carcinogenesis [211].  In previous studies, it was reported that 
the expression of miR-126 is significantly reduced in colorectal cancer compared to non-
tumor tissue, where miR-126 is involved in suppressing excessive proliferative activity 
[211, 230]. miR-126 targets several mRNAs, that have a complementary sequence 
within their 3’UTR region such as PI3K/AKT and VCAM-1 [211, 225]. Previously we 
have demonstrated the ability of polyphenolics to increase the expression of miR-126 in 
LPS-treated human colon-derived CCD-18Co myofibroblast cells [222]. Pomegranate 
extract increased the expression of miR-126 (Figure 45 gFig. 3G) and correspondingly, 
this was accompanied by reduction of PI3K, AKT and VCAM-1 mRNA and protein 
expression in AOM-treated rats (Figure 45 c,d e and f).  
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Figure 45 Effects of pomegranate juice on the inflammatory and the mTOR signalling pathways in AOM 
treated rats (a) Pg juice decreased the expression of COX-2 and iNOS mRNA and (b) protein in AOM 
treated rats. (c) Pg juice suppressed the expression of VCAM-1 and NF-kB mRNA and (d) protein in 
AOM treated rats. (e) Pg juice decreased in the expression of IGF and pPI3K accompanied by decreased 
expression of pAKT and pmTOR mRNA and (f) protein levels in AOM treated rats. (g) Pg juice increased 
the expression of miR-126 in AOM treated rats. All experiments were performed as described in the 
material and method section, and result were expressed as mean ± SE.* indicates significant changes at 
p<0.05 
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Pg reduces cell viability and increases markers for apoptopsis in HT-29 colon cancer 
cell lines 
The cytotoxic activities of Pg were confirmed in HT-29 human colon cancer 
cells. The result showed a concentration-dependent decrease in cell viability in HT-29 
cells after treatment with Pg (5-25 µg/ml) after 48 and 72h (Figure 46a). Reduced cell 
viability was accompanied by an increase of the activated form of capase-3, a primary 
apoptosis-executing enzyme, and the cleaved form of its substrate Poly (ADP-ribose)-
polymerase1 (PARP) (Figure 46b).  
Pg decreases inflammation and angiogenesis in HT-29 colon cancer cell lines 
Previously, we have shown the anti-inflammatory activities of polyphenols 
from pomegranate in breast cancer [50]. In AOM-injected rats, Pg inhibited the 
expression of inflammatory markers, such as VCAM-1. Similarly, in colon cancer cells, 
Pg decreased the expression of inflammatory markers, pAKT, NF-κB p65, VCAM-1, 
ICAM-1, COX-2 and angiogenesis marker vascular endothelial growth factor (VEGF) 
mRNA and protein (Figure 46c and d). However, there was no changes of VEGF 
expression by Pg in vivo study. 
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Figure 46  Effects of Pomegranate extract on the inflammatory and the mTOR signalling pathways in HT-
29 human colon cancer cell lines (a) Pg extract inhibited proliferation in human colon cancer cells. (b) Pg 
extract induced the protein expression of apoptosis-associated proteins (Cleaved caspase-3 and cleaved 
PARP). (c) Pg decreased the expression of inflammatory markers, NF-κB p65, VCAM-1, ICAM-1and 
angiogenesis marker vascular endothelial growth factor (VEGF) mRNA and (d) protein in HT-29 human 
colon cancer cells. (e) pomegranate extract increased the expression of miR-126 In HT-29 cells. (f) pAKT, 
and Cox-2 protein expression. Cells were treated with solvent DMSO (control) or different concentration 
of Pg (5-25 µg/ml) for 24 h. All experiments were performed as described in the material and method 
section and were performed at least three times, and result were expressed as mean ± SE.* indicates 
significant changes at p<0.05. 
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Pg increases the expression of miR-126 in HT-29 cells 
In HT-29 cells, pomegranate extract increased the expression of miR-126 (Fig. 
4E) and this was accompanied by reduction of PI3K/AKT and VCAM-1 mRNA and 
protein expression (Figure 46c, d and f).To further understand whether the underlying 
mechanisms of Pg with PI3K and VCAM-1 are based on an increase in miR-126, HT-29 
cells were transfected with the miR-126 antagomir (inhibitor). When transfected cells 
were treated with 10 µg/ml pomegranate polyphenols extract, this repression of miR-126 
by the antigomer treatment was reversed by Pg (Figure 47a) and this was accompanied 
by a decreased expression of VCAM-1 mRNA and protein in transfected cells that were 
treated with Pg (Figure 47 and c). Additionally, when cells were transfected with the 
miR-126 antagomir, the  mRNA expression of PI3K was increased, and  the expression 
of mRNA of PI3K were partially reversed by the treatment of 10µg/ml pomegranate 
polyphenols (Figure 47d). These findings indicate that Pg increases miR-126 and it is 
involved in the reduction of VCAM-1 and the suppression of PI3K/AKT in HT-29 colon 
cancer cells. 
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Figure 47 Effects of pomegranate extract on miR-126 levels and its target genes in HT-29 cells transfected 
with Ant.miR-126 (a) Pg extract reversed this repression of miR-126 by the antigomer treatment. Cells 
were transfected with 20nM Ant. miR-126, and were treated with 10 µg/ml Pg extract (b) the reversed 
expression of miR-126 was accompanied by a decreased expression of VCAM-1 mRNA and (c) protein in 
HT-29 colon cancer cells were transfected with 20nM Ant. miR-126. (d) induced mRNA expression of 
PI3K was partially reversed by the treatment of 10 µg/ml pomegranate polyphenols in transfected cells. 
All experiments were performed as described in the material and method section and were performed at 
least three times, and results were expressed as mean ± SE.* indicates significant changes at p<0.05 
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Discussion 
In this study, we demonstrated the cancer-preventive and therapeutic activities 
of polyphenolics in pomegranate through the suppression of cell proliferation and 
inflammation. The number of HMACF was significantly decreased and the percentage 
of proliferative cells by Pg treatment in azoxymethane (AOM)-treated rats.  In order to 
confirm in vivo findings, the proapoptotic and anti-inflammatory effects of pomegranate 
polyphenolics were also investigated in vitro, in HT-29 colon cancer cells, where Pg 
induced apoptosis and inhibited cell proliferation. Moreover, similar results were 
observed in HT-29 colon cancer cell lines where Pg upregulated the expressions of 
capase-3, a primary apoptosis-executing enzyme, and poly (ADP-ribose)-polymerase1 
(PARP1) in HT-29 cells .  
Polyphenols extracted from pomegranate induced antioxidant, anti-
inflammatory, and anti-tumorigenic effects in colon cancer and other cancer models [49, 
50, 68, 109, 119]. In our previous studies, we demonstrated the cytotoxic effect of 
pomegranate polyphenols in breast cancer BT474 cells and the inhibition of tumor 
growth by Pg in anthymic nude mice bearing BT474 cells as xenografts [50]. Previously, 
pomegranate polyphenols induced apoptosis modulating caspase-3 and targeted multiple 
pathways in several cancer cell lines including breast, prostrate, liver, lung and skin 
cancer [47, 49, 50, 106, 109, 217]. In vitro data in this study demonstrated similar 
results.  
Common colon cancer and inflammatory markers such as VCAM-1 and NF-κB 
mRNA and protein expression were decreased both in vitro and vivo model by Pg. 
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Previous studies demonstrate that pomegranate polyphenols decreased inflammation and 
lung-tumor growth in mice by decreasing the activation of NF-κB [69, 106]. NF-κB 
plays a central role in inflammatory pathways, and controls  oncogenes and tumor 
suppressor genes, as well as adhesion molecules VCAM-1 [231]. Cell adhesion 
molecules such as VCAM-1 disrupt normal cell differentiation, which in turn leads to 
neoplastic transformation, progression, angiogenesis and metastasis of cancer cells. Thus 
increased expression of VCAM-1 possibly influences colon cancer progression [232]. In 
this present study, Pg suppressed the expression of VCAM-1 in AOM treated rats. 
Similar results were observed in HT-29 colon cancer cells which were accompanied by 
reducing angiogenesis marker vascular endothelial growth factor (VEGF). 
In colorectal cancer patients and rodents with chemically induced colon cancer, 
chronic inflammatory markers such Cox-2 and iNOS are up-regulated [212, 226, 233]. 
Excessive nitric oxide (NO) induced the expression of Cox-2, which in turn controls cell 
proliferation, inflammation and may inhibit apoptosis in colon cancer cells [233, 234]. 
Thus upregulation of Cox-2 can increase cell proliferation [223, 235]. Previously it was 
shown that pomegranate polyphenols suppressed the expression of Cox2and iNOS, and 
inhibited cell proliferation by inducing cell cycle arrest and apoptosis in HT-29 colon 
cancer cells [119]. In this study, Pg decreased mRNA and protein expression of Cox-2 
and iNOS in AOM treated rat model (Fig. 3A and B) and Cox-2 protein level in HT-29 
human colon cancer cell. Pg inhibited cell proliferation in HT-29 colon cancer cells and 
also in AOM rat model showed by Ki-67 staining and this was accompanied by the 
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decrease in the number of HMACF, a colon cancer biomarker in rats treated with Pg 
juice . 
Previous studies have suggested the potential role of small non-coding 
microRNAs (miRNAs) in the pathogenesis of cancer and its control of diverse biological 
processes including cell proliferation, development, differentiations, maintenance and 
carcinogenesis [224]. miRNAs are known to function as tumors suppressors or 
oncogenes. In order to investigate the underlying mechanisms of the down-regulation of 
VCAM-1 and the PI3K/AKT pathway, the potential role of tumor suppressor miR-126, a 
colonic prognostic marker,  involved in the anti-inflammatory activity by targeting 
VCAM-1 [225] was investigated. Pg decreased expression of VCAM-1 which was 
accompanied by up-regulation of miR-126 in vivo and vitro. VCAM-1 is regulated by 
miR-126 via a target-binding site in the 3’ UTR region of the VCAM-1 mRNA [225]. 
To confirm the involvement of miR-126, a specific antagomir for miR-126 (as-miR-126) 
was used to decrease miR-126 expression and to increase the expression of VCAM-1, 
where Pg partially but significantly reversed the effects of the antagomir. 
Additionally, findings show that Pg down-regulates the expression of IGF, 
PI3K and AKT.  Pg reduced the activation of NF-kB and the phosphorylation of PI3K 
p85b, and AKT, and this is consistent with our previous finding where pomegranate 
extract decreased the expression of and phosphorylation of NF-kB and the PI3K/AKT 
pathways [50]. Also it was shown that Pg modulated expression of Insulin growth factor 
(IGF) and PI3K/AKT which is crucial in the pathogenesis of colon cancer. The 
PI3K/AKT pathway controls cell survival mechanism through phosphorylation of 
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downstream targets such as NF-kB and mammalian target of rapamycin (mTOR). The 
regulatory p85b subunit of PI3K has been shown to be the direct target for miR-126 in 
colon cancer cancer [211]. The decreased expression of PI3K p85b was accompanied by 
an upregulation of miR-126 as well as decreased phosphorylation of AKT and reduced 
phosphorylation of mTOR.In order to confirm the involvement of miR-126 in the 
regulation of PI3K p85β, a specific antagomir for miR-126 (as-miR-126) was used. The 
antagomir for miR-126 decreased the expression of miR-126 in vitro and increased the 
expression of the PI3K p85b subunit. Pg reversed the effects of the antagomir 
significantly. As found in vivo in rats, CCD-18Co colon myofibroblast cells showed 
significant reduction of miR-126 and increased expression of PI3K p85b subunit [211]. 
It has to be noted that animals in this study treated with Pg gain less body 
weight compared to control animals, even though their caloric intake was increased. 
Previous studies with polyphenolics indicated that the consumption of polyphenolics 
caused a reduction of weight gain in animals [236, 237]. It has previously been reported 
that weight loss had beneficial effects on biomarkers of inflammation in rats [236-238]. 
Therefore, in this study, it is not conclusively clear, whether the observed anti-
inflammatory effects of Pg polyphenolics are derived from a direct interaction of 
polyphenolics with inflammatory pathways or whether at least part of the benefits is 
derived from the anti-inflammatory effects of reduced weight-gain in animals treated 
with Pg. Overall, there was no correlation between weight gain and the number of 
HMACF (R2=0.0956, p=0.2439), for this reason, the effects of reduced weight-gain 
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caused by Pg may not have significantly contributed to the reduction of HMACF caused 
by Pg. 
Conclusion  
In summary, pomegranate polyphenols (Pg) exerted cytotoxic and anti-
inflammatory effects in AOM-treated rats and colon cancer cells. Interactions of Pg with 
miR126/VCAM-1 and miR126/PI3K/AKT/mTOR axes Figure 48) were identified as 
mechanisms that at least in part appear to be involved in the anti-inflammatory and anti-
proliferative activities of pomegranate polyphenolics. 
 
 
 
Figure 48 Schematic representation showing molecular mechanisms involved in colon carcinogenesis 
treated with Pg polyphenols. Pg targeted miR126 by modulating both miR126/VCAM-1 and 
miR126/PI3K/AKT/mTOR axe
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CHAPTER V 
CHOLOROGENIC ACID RICH PLUM JUICE INHIBITED AOM TREATED 
COLORECTAL ABERRANT CRYPT FOCI (ACF): POTENTIAL ROLE OF MIR143/ 
MTOR PATHWAY 
 
 
Summary 
The antitumorigenic cytotoxic, anti-inflammatory and antioxidant activities of 
polyphenols, chlorogenic acid and neo-chlorogenic acid in plum juice (PL) have been 
previously studied and were evident in various cancer models. Our preliminary result 
exhibited anti-inflammatory property of PL which decreased the expression of VCAM-1, 
a marker for colon cancer, and the activation of PI3K/AKT, that is crucial in the 
regulation of cell survival and proliferation in AOM treated in vivo study. In addition, 
PL also increased microRNA143, which targets mTOR.   
Hence, the objective of this study was to investigate the underlying cytotoxicity 
mechanisms involving miR143/PI3K/AKT/mTOR in PL-mediated anti-inflammatory 
and anti-carcinogenic effects in vivo and in vitro.  
Sprague Dawley rats (n=10/group) received PL juice (1345.68ppm GAE) or a 
polyphenol-free control beverage ad libitum for 10 weeks and were injected with 
azoxymethane (AOM) subcutaneously (15 mg/kg) at weeks 2 and 3.  
Consumption of PL juice suppressed the number of high multiplicity aberrant 
crypts foci (HMACF>4 ACF) by 47.98% (P<0.05) and significantly lowered 
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proliferation of mucosa cells. The results were accompanied by a downregulation of 
nuclear factor kappa B (NF-κB), inducible nitric oxide synthase (iNOS), 
cyclooxygenase-2 (COX-2), vascular adhesion molecule-1 (VCAM-1) and mRNA and 
protein. PL also inhibited phosphorylation of PI3K/AKT, and mTOR/HIF-1α pathways. 
PL increased the expression of miR143 expression.  
In summary, PL suppressed number of HMACF formation, colon tumorgenesis 
where microRNA-143-regulated pathways significantly contributed in the underlying 
cytotoxicity mechanisms. 
Introduction 
According to the American cancer society colorectal cancer is the third leading 
cause of death in the US with an estimated of 102,480 new cases of colon cancer and 
40,340 new cases of rectal cancer diagnosed in 2013 and record showed 50,830 deaths 
from colorectal cancer [2, 3]. The Incidence of colorectal cancer and the associated 
mortality rates were increasing worldwide and the lifetime risk of developing colorectal 
cancer is about 1 in 20 [2, 3]. In addition to available therapies there is a need to develop 
novel therapeutic agents in the prevention and treatment of colorectal cancer [91-93]. 
Epidemiological, preclinical and clinical studies suggest that a diet rich in natural 
polyphenolics plays an important role in the protection against colonic inflammation and 
colon cancer [45, 46, 93, 95]. Plant polyphenols have drawn immense attention due to 
potential antioxidant, anti-inflammatory, and anti-tumorigenic effects in colon cancer 
and other cancer models and have shown potential as a cancer-suppressing agents [49, 
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50, 74, 119, 239]. Polyphenols are known to target different molecular pathways in 
cancer cell lines with less toxic effects in normal cell lines [50, 100, 133].  
Plums (Prunus domestica) belonging to the family Rosaceae, contains a 
mixture of polyphenols that exerts anti-cancer and antioxidant properties [155, 240]. In 
commercial available variety of plums, the most predominant and therapeutically 
relevant compounds are flavonols, (the flavan 3-ols catechin, and epicatechin; the 
flavonols quercetin 3-glucoside), anthocyanins (cyanidin 3- galactoside, 3- glucoside, 3- 
rutinoside, and 3-acetylglucoside), procyanidins (dimers and trimmers), phenolic acids 
(chlorogenic acid and neo-chlorogenic acid) and carotenoids [73-75, 240]. 
 Literature showed chlorogenic acid and neo-chlorogenic acid present in fruits 
are known to function as chemoprevention and therapeutic agent in several cancer cell 
lines such as breast cancer,  U937 leukemia cells, and also in AOM treated in Fisher 344 
male rats  [74, 75, 155, 241]. Recent studies have shown that several other polyphenols 
such as flavonoid quercetin and stilbene and resveratrol prevent the formation of 
colorectal aberrant crypt foci (ACF) and inhibit the occurrence of colon tumors in rats 
injected with azoxymethane (AOM). Polyphenolic constituents of grapefruit and 
blueberry suppressed HMACF formation in animal studies [45, 233]. Similarly plum 
also function as a cancer blocking agent and cancer suppressing agents by targeting 
several cellular pathways at the cancer initiation stage. Plum also protect cells from 
oxidative stress by scavenging ROS and other oxidative species, and known to detoxify 
carcinogen activity and initiate DNA repair [155, 242]. In addition, Plum also suppress 
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cancer promotion and progression stages by down regulating activation of transcription 
factor NF-kB and initiates tumor cell apoptosis [242]. 
 In our preliminary studies, we have demonstrated the effect of plum juice (PL) 
in carcinogen, AOM treated rats. PL was effective in suppressing the high multiplicity of 
ACF (HMACF〉4 aberrant crypts/focus) and decreased cell proliferation in the 
carcinogen, AOM treated rats. PL inhibited the expression of colon marker VCAM-1 
expression and also suppressed the phosphorylation of PI3K/mTOR /HIF1α signaling 
pathways in AOM treated rats. In addition PL also targeted inflammatory marker such as 
iNOS and COX-2 and decreased expression of iNOS and COX-2 through inhibition of 
NF-kB activation.  
Hence, the objective of this study was to understand the anti-inflammatory, anti 
tumorogenic and antiproliferative properties of polyphenolic mixture present in PL juice 
which exerted chemoprevention and chemotherapeutic activities in cancer model with 
low toxicity in control groups. 
Materials and methods 
Experimental juice and extract  
Control juice or Plum juice groups rats. Commercial varieties of red-fleshed 
plum ‘Black Splendor’ (BS) were collected at a mature firm stage from California.  
Upon arrival at the Texas A&M University, fruits were used for the extraction of 
phenolic compounds. Plum juice (PL) was obtained from a total of 100 g of plum fruit 
with flesh and skin was chopped, enzyme pectinase was added to it and then boiled at 
water bath for 1 h until the temperature reached at 70 degree centigrade. Extracts were 
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filtered through whatman #1 filter paper. The remaining aqueous extracted plum juice 
was saved at 4 degree centigrade. For calorie adjustment, 15.7g sugar and 0.05g citric 
acid were added in 100ml of Control juice. Total phenolic content in the plum juice was 
measured spectrophotometrically by the Folin-Ciocalteu assay against an external 
standard of gallic acid. Individual pholyphenolics (1345.68 mg/L GAE; gallic acid 
equivalent) in the plum juice were characterized using a Waters Alliance 2690 (Milford, 
MA) HPLC system [50]. 
Measurement of antioxidant enzyme activity 
Activities of SOD (Superoxide Dismutase), CAT (Catalase), and GPx 
(Glutathione peroxidase) in colonocytes were measured spectrophotometrically using 
assay kits from Cayman Chemical(Ann Arbor, MI) according to the manufacturer’s 
protocol. The protein extract was obtained as described in the Western blot procedure. 
Samples were assayed in duplicate in 96 well microplates with standards. Microplates 
were read on a FLUOstar Omega plate reader (BMG Labtech Inc. Durham, NC). Briefly, 
SOD activity was evaluated by measuring the rate of generation of a chromophore at 525 
nm. CAT activity was calculated at 520 nm by measuring absorbance of 
quinoneimenedye. GPx was evaluated at 340 nm indirectly by oxidation of NADPH to 
NADP+. Activity was normalized to protein concentration as determined by Bradford 
reagent (Bio-rad, Hercules, CA). 
Reagent  
All primers were purchased from Integrated DNA Technologies (San Diego, 
CA). mirVana TM extraction kit, reverse transcription (RT) and real-time PCR 
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amplification kits were purchased from Applied Biosciences (Foster City, CA  as well as 
scrambled miRNA were from Dharmacon, Inc. (Lafayette, CO).) [50].  Antibodies 
against COX-2, iNOS, HIF-1alpha, mTOR, pPI3K85 were purchased from Cell 
Signaling Technology (Beverly, MA). All other antibodies were purchased from Santa 
Cruz Biotechnology Inc. (Santa Cruz, CA). Western lighting chemiluminescence reagent 
was purchased from Perkin-Elmer Life Sciences (Waltham, MA).   
Animal treatment and tissue sampling 
The animal use protocol was approved by the Institutional Animal Care and 
Use Committee of Texas A&M University. Twenty male Sprague-Dawley rats (3 week-
old) were purchased from Harlan Teklad (Houston, TX) and were distributed randomly 
by weight into control juice and plum juice groups. Rat groups were kept in suspended 
cages in a room controlled at a temperature of 23±2°C, humidity of 55±5% and 12 h 
light/dark cycle,  and had free access to regular food pellets, rat chow and experimental 
juices. All animals received intra-peritoneal injection of azoxymethane (AOM; 15 mg/kg 
body weight; Sigma Chemical Co., St Louis, MO) twice at 2 and 3 week after starting 
experimental diets. Rats were sacrificed 6 weeks after the second AOM treatment, and 
colon tissues were collected. From the distal end of each rat colon one centimeter 
sections were cut, and fixed in 4% paraformaldehyde (PFA). Half of the colon was fixed 
at 70% EtOH for aberrant crypt foci (ACF) assay and the other half was gently scraped 
for collecting protein and RNA samples   [212, 226].  
ACF counting 
Half of the colon was fixed at 70% EtOH for aberrant crypt foci (ACF) assay. 
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After 24 h  of fixation in 70% EtOH, tissue was stained with 0.5% methylene blue for 1 
min, and the total number of high multiplicity ACF (HMACF; foci containing 4 or more 
aberrant crypts) was counted under a light microscope using 40x magnification [212, 
226]. HMACF and ACF were assessed over the entire length of the colon mucosa and 
also within segments.  The mucosa was divided from the distal through the proximal 
end. 
Cell proliferation assay 
For cell proliferation, analysis Ki-67 immunohistochemistry was performed. 
Colon tissues were dehydrated, embedded in paraffin and cut into 4 µm thick sections. 
The distal colon section (1cm) was fixed in 70% ethanol and then embedded in paraffin. 
Paraffin embedded sections were stained with Ki67 [243]. The primary antibody against 
Ki-67 (Dilution 1:50, BD Pharmingen, San Jose, CA) was treated on the sections, and 
sections were incubated with biotinylated anti-mouse IgG from the Vectastain ABC Elite 
kit (Vector Lab, Burlingame, CA). Ki-67-containing nuclei, indicative of proliferating 
cells, showed up as brown spots within colonic crypt columns. Twenty-five crypt 
columns per rat were identified for analysis. 
Quantitative RT-PCR 
Total RNA from the colon mucosal scraping was isolated using the mirVana™ 
miRNA Isolation Kit. Equal amount (1ug) of mRNAs was converted to cDNA using a 
reverse transcription kit (Invitrogen Corp., Grand Island, NY) [212, 226]. Real-time 
PCR reactions were performed using 2uL of cDNA using a Reverse Transcription Kit 
(Invitrogen). SYBR Green PCR Master Mix (Applied Biosystems Inc., Foster City, CA) 
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was used for the qPCR analyses on Applied Biosystems 7900HT Fast Real-Time PCR 
system (Applied Biosystems Inc., Foster City, CA). The sequence of primers was 
designed using Primer3, online primer design tool and were obtained from Integrated 
DNA Technologies (Coralville, IA). GAPDH was used as the endogenous loading 
control[50]. 
Western blotting 
The mucosal scrapings were homogenized in a protein buffer (500mM Tris-
HCL, 1M Sucrose, 200mM EDTA, 100mM EGTA, 0.4M NaF, 10% Triton X-100, 
10mM Sodium Orthovanadate, and Protease Inhibitor Cocktail), then centrifuged at 
15,000 g for 20 min at 4°C, and the supernatant was stored in a 80°C freezer[212, 226]. 
60ug of protein was loaded onto 10% electrophoresis gel, followed by electrotransfer 
onto PVDF membranes. The blots were probed with the primary antibodies against 
VCAM-1 (Santa Cruz biotechnology, Santa Cruz, CA), Cox-2, , iNOS, HIF-1alpha, 
mTOR, pPI3K85 (Cell signaling, Danvers, MA) and b-actin (Sigma, St Louise, MO) 
[50]. We performed western blotting as previously mentioned [50, 139, 140]. Proteins 
were visualized with a Kodak Molecular Imaging System (Carestream Health, 
Rochester, NY) [50]. 
Multiplex bead assay 
The protein extract (20ug) from each tissue was used to determine the relative 
abundance of the phosphorylation status and total protein in the Akt/mTOR signaling 
(kit contained Akt, GSK3β, GSK3α, IGF1R, IR, IRS1, mTOR, p70 S6 kinase, PTEN, 
RPS6, and TSC2) using the multiplex kits (#48-611, #48-612, Millipore) according to 
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the manufacturer’s protocol. Multiplex analysis was performed by the Luminex L200 
instrument (Luminex, Austin, TX), and data were analyzed by Luminex xPONENT 
software [210]. 
SCFA GC/MS assays 
SCFA analysis was performed using a gas chromatograph (HP 5890, Hewlett-
Packard, Palo Alto, CA, USA) coupled to a quadrupole mass spectrometer (HP-5989A). 
Sample preparation for short chain fatty acids with GC/MS assay is as follows. Grinded 
feces (0.5g) were vortexed in 2N HCL for 30 minutes followed by centrifugation at 
3000rpm for 20 min. The upper phase was transferred to C18 cartridge after adding 
200mM internal standard (d7-butyric acid). The sample was then eluted with diethyl 
ether. Removing the top layer was repeated after adding diethyl ether and vortexing for 
15min. After adding MTBSTFA (N-tert-butyldimethylsilyl-N methytrifluoracetamide), 
samples were transferred to vials for the GC/MS injection. 
Statistical analysis 
Quantitative data represent mean values with standard error. Data were 
analyzed by one way ANOVA using Tukey’s post hoc test (p<0.05) using SAS version 9 
(SAS Institute Inc., Cary, NC)[50]. 
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Results 
Chemical analysis of plum (PL) juice 
The polyphenolics profile of Plum (PL) juice is representative of 100%.[73-75, 
240]. The chromatographic profiles show presence of phenolic acids (chlorogenic acid 
and neo-chlorogenic acid) (Figure 49a).  
Plum juice intake, food intake and weight in AOM treated rats          
In the rat study the concentration of total soluble phenolics of plum (PL) juice 
used was 1345.68mg/L GAE. Every alternative day the intake of PL and control 
beverage was measured. Overall, no significant differences were observed between the 
intake of PL and control group (Figure 49 b). For the first 9 days, the intake of PL was 
significantly lower compared to the control group, likely because of the change of taste. 
For the initial 48h after the AOM injection (week 2 and 3), the overall intake of liquid 
was significantly lower in the control group compared to the PL-treated group by 30ml 
and 15ml, respectively, potentially due to ameliorating effects of PL on the adverse 
effects of AOM. The control group gained more weight compared to the PL group, 
where the final average body weight of the control group was 43g above the PL group 
(Table 6). Similarly the intake of solid food was significantly lower by 6 g/day in the 
control group compared to the PL group. 
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Figure 49 Representative chromatogram of polyphenolic compounds in plum juice and the daily juice 
consumption by rats (a) effects of plum juice on final body weight, food intake, and juice intake (b) the 
daily juice consumption by rats was measured every day for 10 weeks. Values are mean ± SE, n=20  
 
 
 
Table 6 Effects of plum juice on final body weight, food intake, and juice intake 
 
Each value is a mean ± SD (n=20). Values are statistically significant at *p<0.05. ns means not 
significantly different. Food intake was measured as the mean (± SD) weight (g) of food intake per 48 h 
period at 9 weeks after the second AOM injection. Juice intake was calculated as the mean (± SD) volume 
(ml) of juice consumed for whole study 
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Antioxidant enzyme activity 
Antioxidant enzyme activities for GPx, SOD and CAT were greater in the 
control group as compared to the plum juice group (Figure 50). In the colon mucosa 
tissue GPx, SOD and CAT enzyme activities were significantly suppressed 70%, 45% 
and 80% respectively in the PL group than control (Figure 50a) but in plasma only SOD 
expression were significantly reduced 50% in PL group (Figure 50b). Thus antioxidant 
activity of plum induced the expression of GPx, SOD and CAT [244]. 
     
 
Figure 50  Effects of plum juice (PL) on antioxidant enzyme activity in AOM treated rats (a) antioxidant 
enzyme activities for GPx, SOD and CAT were significantly higher in the control group as compared to 
the plum juice group (in tissue). (b) antioxidant enzyme activities for SOD were significantly higher in the 
control group as compared to the plum juice group (in plasma). All experiments were performed as 
described in the material and method section, and result were expressed as mean ± SE.* indicates 
significant changes at p<0.05 
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Colorectal aberrant crypt foci (ACF) and high multiplicity ACF (HMACF > 4 aberrant 
crypts/focus) in AOM-treated rats 
Both aberrant crypt foci (ACF) and high multiplicity ACF (HMACF), markers 
for the initial stages of colon cancer and these preneoplastic lesions are found in human 
and animal colon cancer models [212, 245, 246]. In the more distal segments, the 
number of HMACF was significantly reduced in rats treated with plum juice by 47.98% 
(P<0.05) to the control group (Figure 51a).  
Ki67 staining for cell proliferation index 
Cell proliferation index was calculated by using Ki67 immunohistochemistry 
staining of mucosal tissue harvested from the colon of AOM-treated rats and control 
groups. (Figure 2A). The colon mucosa of control group rats showed a significant 
induction of Ki67-positive nuclear staining compared to the PL-treated group. In the 
control group Ki-positive nuclei staining in the colon mucosa were 34.24% of the cells 
and in PL treated group showed 25.82% of cells. Thus PL group showed a significant 
reduction of 8.42% compared to the control group (P≤0.0127) (Figure 51b). 
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Figure 51 Effects of plum uice on lesion formation and colonocyte proliferation (a) the number of 
HMACF was significantly decreased by the plum treatment by 47.98% compared to the control group 
(p=0.04) (b) plum juice inhibited cell proliferation compared with the control juice group. Values are 
mean ± SE, n=20. *P < 0.05 
 
 
 
PL juice suppressed the expression of inflammatory enzyme Cox-2, iNOS, NF-κB (p65) 
VCAM-1 in rats treated with AOM 
In this study we investigated the anti-inflammatory and anticarcinogenic 
activities of PL juice in rats treated with AOM. PL juice polyphenols decreased 
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expression of COX-2, iNOS, NF-κB and VCAM-1, mRNA (Figure 52a and b). PL juice 
also suppressed protein expression of VCAM-1 (Figure 52d).  
PL juice modulated AKT/PI3K/mTOR in AOM-induced rats           
In this study, plum juice polyphenols decreased pPI3K and pAKT mRNA and 
PI3K protein expression (Figure 52c and d). This was accompanied by decreased 
expression of mTOR and its downstream HIF-1α, protein (Figure 52d). Multiplex bead 
assay also showed similar PI3K and mTOR protein result.  As previous literature 
showed PI3K/AKT/ mTOR signaling pathway play a key role in carcinogenesis for 
several types of cancer such as colon cancer [211, 212]. PI3K/AKT regulates cell 
growth, proliferation and glucose metabolism and influences cell survival pathways 
through phosphorylation of several downstream targets such as mammalian target of 
rapamycin (mTOR) and which in turn controls HIF-1α, [213-215]. 
PL increases miRNA -143 in AOM-treated rats  
Small non-coding microRNAs (miRNAs) are known to influence cancer 
progression by controlling several biological processes such as cell development, 
differentiation and maintenance. In our previous study we have shown the effect of 
polyphenols which target different miRNA that play important role in the progression of 
breast cancer [50]. In this study miRNA screening was performed. PL induced the 
expression of tumor suppressor miR143.  miRNA 143 targets several mRNAs, that have 
a complementary sequence within their 3’UTR region such as of rapamycin (mTOR). PL 
extract induced the expression of miR-143 (Figure 52e) and correspondingly, this was 
accompanied by reduction of mTOR expression in AOM-treated rats (Figure 52c and d). 
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Figure 52 Effects of plum juice (PL) on the inflammatory and the mTOR signalling pathways in AOM 
treated rats (a) PL juice decreased the expression of COX-2 and iNOS mRNA and (b) VCAM-1 and NF-
κB mRNA (c) PI3K, AKT and mTOR mRNA (d) PL juice suppressed the expression of and (D) VCAM-
1, PI3K p85, mTOR protein in AOM treated rats (E) PL juice decreased in the expression of IGF and 
pPI3K accompanied by decreased expression of pAKT and pmTOR mRNA and (F) protein levels in AOM 
treated rats. (e) PL juice increased the expression of miR-143 in AOM treated rats. All experiments were 
performed as described in the material and method section, and result were expressed as mean ± SE.* 
indicates significant changes at p<0.05 
 
SCFA GC/MS assays 
Acetic, Propionic, Isobutyric, Butyric, Isovaleric and Valeric acids were 
measured in the feces of control and PL group. Acetic acid and Butyric acid were 
reduced in PL group but no significant differences were observed (Figure 53). 
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Figure 53 Effects of plum juice (PL) on the SCFA (Short Chain Fatty Acid) GC/MS assaysin AOM treated 
rats Acetic acid and Butyric acid were reduced in PL group but no significant differences were observed. 
No significant changes observed in propionic, isobutyric, butyric, isovaleric and valeric acids. All 
experiments were performed as described in the material and method section, and result were expressed as 
mean ± SE.* indicates significant changes at p<0.05 
 
 
Discussion 
The Incidence of colorectal cancer and its associated mortality rate are 
increasing worldwide. In addition to available therapies, there is a need to develop novel 
therapeutic agents in the prevention and treatment of colorectal cancer [91-93]. Several 
previous studies have shown the cancer-preventive and cytotoxic effects of polyphenols 
from green tea, blueberries, grapefruit, and pomegranate,  as well as the flavonoids 
quercetin, stibene and resveratrol in suppressing the development of high multiplicity 
aberrant colorectal crypt foci (HMACF) [46, 131, 233, 239, 247, 248]. Plum juice with 
chlorogenic acid and neo-chlorogenic acid plays a key role in chemoprevention and as a  
therapeutic agents in several cancer cells lines such as breast cancer,  U937 leukemia 
cells and also in AOM treated in Fisher 344 male rats  [74, 75, 155, 241].  
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In this study we have investigated the cytotoxic and anti-tumorigenic effect of 
polyphenolics present in plum juice through the suppression of cell proliferation and 
inflammation. The number of HMACF was significantly decreased as well as the 
percentage of proliferative cells in azoxymethane (AOM)-treated rats. Plum juice rich in 
chlorogenic acid induced antioxidant, anti-inflammatory, and anti-tumorigenic effect in 
AOM treated rats. PL suppressed the expression of common colon cancer and 
inflammatory marker VCAM-1 and NF-κB in AOM treated rats [58]. NF-κB plays a 
central role in inflammatory pathways and the control of oncogenes and tumor 
suppressor genes, as well as adhesion molecules VCAM-1 [58]. Cell adhesion molecules 
such as VCAM-1 disrupt normal cell differentiation, which in turn leads to neoplastic 
transformation, progression, angiogenesis and metastasis of cancer cells [58]. Our 
preliminary data showed the effect of plum juice in the suppression of NF-κB and 
VCAM-1 expression in AOM treated rats. 
In addition other chronic inflammatory markers such as Cox-2 and iNOS are 
up-regulated [212, 226, 233, 249] in colorectal cancer patients and rodents with 
chemically induced colon cancer. Excessive nitric oxide (NO) induced the expression of 
Cox-2, which in turn controlled cell proliferation, inflammation and might inhibited 
apoptosis in colon cancer cells [233]. Our data showed PL inhibited expression of Cox-2 
and iNOS mRNA in AOM treated rat model. PL also inhibited cell proliferation in the 
AOM rat model showed by Ki67 staining and this was accompanied by the lower 
number of HMACF. 
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PL also targeted AKT/PI3K/mTOR pathway.  Here, PL suppressed the 
activation of NF-kB by inhibiting the phosphorylation of PI3K/p85 and AKT and this 
was consistent with our previous finding where polyphenolic extract decreased the 
expression of and phosphorylation of NF-kB and PI3K/ AKT pathways [50]. The 
suppressed expression of PI3K/p85 was accompanied by decreased phosphorylation of 
AKT and mTOR and its downstream HIF-1 α and RPS6.  
Additionally, our findings investigated the underlying mechanisms of down-
regulation of mTOR, possible role of tumor suppressor miRNA 143. Decreased 
expression of mTOR was accompanied by increased expression of tumor suppressor 
miRNA 143 by plum juice. mTOR expression is controlled by miR-143 via a target-
binding site in the 3’ UTR region of the mTOR mRNA [203, 217, 224, 241].  
Conclusion  
In summary, plum juice polyphenols (PL) showed cytotoxic and anti-
tumorigenic effects in AOM treated rats. Interactions of PL with 
miR143/PI3K/AKT/mTOR pathway were identified as the possible underlying 
mechanisms.
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
 
 
In the presented work the anti-inflammatory and cytotoxic effects of 
polyphenolics relevant to carcinogenesis and tumor-growth were investigated. It was 
shown that ellagitannins and anthocyanin-rich pomegranate extract (Pg) decreased breast 
cancer cell growth and tumor volume through activation of cleaved caspase-3 and Poly 
(ADP-ribose)-polymerase1 (PARP) [186]. We have also investigated the potential role 
of mirna-27a and mirna-155 in cell survival and inflammation, while studying 
cytotoxicity and anti-inflammatory activities of Pg in breast cancer cells and in xenograft 
mice model.  
It was shown that the miR-27a-ZBTB10-Sp axis was involved in Pg-induced 
downregulation of NF-kB and genes involved in survival and angiogenesis. Pg 
modulated miR-155-SHIP-1-PI3K axis in breast cancer model  [185, 191]. Micro-RNA-
mimic and -inhibitor studies demonstrated that both miR-27a and miR-155 are targets of 
Pg and their downregulation plays a significant role in the anti-inflammatory and 
cytotoxic efficacy of pomegranate extract. Overall we have demonstrated that 
pomegranate extract exhibited cytotoxic and anti-inflammatory activities in breast cancer 
cells in vitro and in vivo. In addition there is evidence that these activities are mediated 
in part through the effects of pomegranate extract on miR-27a-ZBTB10-Sp and miR-
155-SHIP1- PIP3-AKT-NF-kB. 
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We further investigated the possible role of miR126-VCAM-1 and miR126-
PI3K/AKT-mTOR in azoxymethane-induced colorectal aberrant crypt foci (ACF) and 
inflammation that was decreased by Pg. It was found that Pg decreased the expression of 
VCAM-1, this and was accompanied by up-regulation of miRNA-126 in vivo and vitro.  
We confirmed the involvement of miR-126 by showing decreased miR-126 and 
increased expression of VCAM-1 by a specific antagomir for miR-126 (ant. miR-126), 
where Pg partially but significantly reversed the effects of the antagomir. The study 
however, could not conclude whether the observed anti-inflammatory effects of Pg 
polyphenolics are derived from a direct interaction of polyphenolics with inflammatory 
pathways or whether at least part of the benefits is derived from the anti-inflammatory 
effects of reduced weight-gain observed in animals treated with Pg. Overall the results 
indicated that Pg polyphenols exerted cytotoxic and anti-inflammatory effects in AOM-
treated rats and colon cancer cells. Interactions of Pg with miR126/VCAM-1 and 
miR126/PI3K/AKT/mTOR axes were identified as mechanisms that at least in part 
appear to be involved in the anti-inflammatory and anti-proliferative activities of 
pomegranate polyphenolics. 
Mango polyphenolics including gallotannins and gallic acid were found to 
inhibit cell proliferation of the breast cancer cell line BT474 through inducing apoptosis 
as demonstrated by an increase in the cleaved product of Poly (ADP-ribose)-
polymerase1 (PARP). The expression of survivin and tumor growth in athymic BALB/c 
nude mice with BT474 xenografts was decreased. In our preliminary data we 
demonstrated that Mg modulates the expression of different miRNA involved in 
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carcinogenesis. Mg modulates the AKT/ PI3K/p85 pathway and reduced the expression 
of mammalian target of rapamycin (mTOR) and its downstream transcription factor 
hypoxia-inducible factor (HIF-1α). The PI3K/AKT/ mTOR axis is well known for its 
involvement in the carcinogenesis progression in  several types of cancer such as colon, 
lung and breast cancer [211, 212]. Mg also reduced expression of angiogenesis marker 
such as vascular endothelial growth factor (VEGF) and its receptor VEGF-R. In 
summary, Mg exhibited antioxidant, anti-inflammatory, anti-carcinogenic and anti-
proliferative activities in breast cancer cells in vitro and in vivo.  
The potential role of the miR143/mTOR pathway was investigated AOM-
induced colorectal aberrant crypt foci (ACF) in rats that were treated with plum 
polyphenolics. Specifically, we have investigated the cytotoxic and anti-tumorigenic 
effect of polyphenolics present in plum juice in the suppression of cell proliferation and 
inflammation. Number of HMACF was significantly decreased as well as the percentage 
of proliferative cells in azoxymethane (AOM)-treated rats that were treated with plum. 
Additionally, plum suppressed the expression of the colon cancer and inflammatory 
markers VCAM-1, Cox-2 and iNOS in AOM treated rats. 
 In addition we observed that PL suppressed the activation of NF-κB, by 
inhibiting the phosphorylation of PI3K/p85 and AKT and this is consistent with our 
previous finding where polyphenolic extract decreased the expression of and 
phosphorylation within the NF-kB and PI3K/ AKT pathways [50]. The suppressed 
expression of PI3K/p85 was accompanied by decreased phosphorylation of AKT and 
mTOR and its downstream targets HIF-1 α and RPS6. In conclusion, results indicate that 
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Plum juice polyphenols (PL) exert cytotoxic and anti-tumorigenic effects in AOM 
treated rats. Interactions of PL with miR143/PI3K/AKT/mTOR pathway were identified 
as the possible underlying mechanisms 
In summary, we have investigated polyphenol-induced anti-cancer effects and 
potential role of miRNA’s in cell survival and inflammation.  Pg exerted cytotoxic and 
anti-inflammatory activities in breast cancer cells and these are significantly mediated 
through the effects of pomegranate extract in the miR-27a-ZBTB10-Sp and miR-155-
SHIP1- PIP3-AKT-NF-kB axes. Pg and plum juice also exhibited cytotoxic and anti-
inflammatory effects in AOM-treated rats. Interactions of Pg with miR126/VCAM-1 and 
miR126/PI3K/AKT/mTOR axes and plum with miR143/PI3K/AKT/mTOR were 
identified as mechanisms that at least in part appeared to be involved in the anti-
inflammatory and anti-proliferative activities of pomegranate polyphenolics. In addition 
Mg exhibited antioxidant, anti-inflammatory, anti-carcinogenic and anti-proliferative 
activities in breast cancer cells in vitro and in vivo by targeting 
miR126/PI3K/AKT/mTOR. Overall, this work will contribute significantly to the 
growing knowledge of how polyphenolics exert their anti-inflammatory, anti-
carcinogenic and cytotoxic activities in breast and colon cancer. 
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